activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	678258	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCOC(=O)CCCc1ccc2ccc3cccc4ccc1c2c34		CHEMBL290544	=	Rate		0.14	CHEMBL3023	Homo sapiens	Rate		0.14
	678258	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCOC(=O)CCCc1ccc2ccc3cccc4ccc1c2c34		CHEMBL290544	=	Rate		0.14	CHEMBL3023	Homo sapiens	Rate		0.14
	685049	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCOC(=O)CCCCCc1ccc2ccc3cccc4ccc1c2c34		CHEMBL288581	=	Rate		0.83	CHEMBL3023	Homo sapiens	Rate		0.83
	685051	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	NC(CO)[C@H](O)/C=C/CCCCCCCCCCNC(=O)c1ccc2ccc3cccc4ccc1c2c34		CHEMBL263205	=	Rate		1.25	CHEMBL3023	Homo sapiens	Rate		1.25
	687570	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCOC(=O)CCCCCCCCCc1ccc2ccc3cccc4ccc1c2c34		CHEMBL43580	=	Rate		0.065	CHEMBL3023	Homo sapiens	Rate		0.065
	694021	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCNc1ccc([N+](=O)[O-])c2nonc12		CHEMBL41887	=	Rate		0.48	CHEMBL3023	Homo sapiens	Rate		0.48
	695399	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCOC(=O)c1ccc2ccc3cccc4ccc1c2c34		CHEMBL277387	=	Rate		1.25	CHEMBL3023	Homo sapiens	Rate		1.25
	702341	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	CN(C)c1ccc(S(=O)(=O)NCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO)c2ccccc12		CHEMBL174861	=	Rate		0.026	CHEMBL3023	Homo sapiens	Rate		0.026
	712815	CHEMBL807607	Rate of phosphorylation of labeled sphingosine derivative by by human SPHK-2 expressed in HEK293 cells relative to rate of D-sphingosine	F	NC(CO)[C@H](O)/C=C/CCCCCCCCCCNS(=O)(=O)c1ccc2ccc3cccc4ccc1c2c34		CHEMBL38414	=	Rate		0.83	CHEMBL3023	Homo sapiens	Rate		0.83
	1662660	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1		CHEMBL314854	=	Activity	%	14.1	CHEMBL3023	Homo sapiens	Activity	%	14.1
	1662666	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	C[C@](N)(CO)CCc1ccc(OCCCCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1		CHEMBL369932	=	Activity	%	119.0	CHEMBL3023	Homo sapiens	Activity	%	119.0
	1662667	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	C[C@](N)(CO)CCc1ccc(OCCCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1		CHEMBL199425	=	Activity	%	6.5	CHEMBL3023	Homo sapiens	Activity	%	6.5
	1662668	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	C[C@](N)(CO)CCc1ccc(OCCCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1		CHEMBL200362	=	Activity	%	9.0	CHEMBL3023	Homo sapiens	Activity	%	9.0
	1662669	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	C[C@](N)(CO)CCc1ccc(OCCCCNc2ccc([N+](=O)[O-])c3nonc23)cc1		CHEMBL199882	<	Activity	%	0.1	CHEMBL3023	Homo sapiens	Activity	%	0.1
	1662670	CHEMBL864560	Rate of phosphorylation by recombinant human SPHK2 using	B	CCCCCCCOc1ccc(CC[C@@](C)(N)CO)cc1		CHEMBL268745	=	Activity	%	22.9	CHEMBL3023	Homo sapiens	Activity	%	22.9
	2013299	CHEMBL902399	Effect on rate of phosphorylation of human recombinant SPHK2 expressed in HEK293 cells	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO		CHEMBL67166	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	2013303	CHEMBL902399	Effect on rate of phosphorylation of human recombinant SPHK2 expressed in HEK293 cells	B	CCCCCCCCc1ccc([C@@H]2C[C@@H](CO)N[C@H]2CO)cc1.Cl		CHEMBL537892	<	Activity	%	0.1	CHEMBL3023	Homo sapiens	Activity	%	0.1
	2013304	CHEMBL902399	Effect on rate of phosphorylation of human recombinant SPHK2 expressed in HEK293 cells	B	CCCCCCCCc1ccc([C@H]2C[C@H](CO)N[C@@H]2CO)cc1.Cl		CHEMBL247903	=	Activity	%	55.0	CHEMBL3023	Homo sapiens	Activity	%	55.0
	2013305	CHEMBL902399	Effect on rate of phosphorylation of human recombinant SPHK2 expressed in HEK293 cells	B	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1		CHEMBL314854	=	Activity	%	13.0	CHEMBL3023	Homo sapiens	Activity	%	13.0
	2634019	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Activity	%	66.97	CHEMBL3023	Homo sapiens	Activity	%	66.97
	2634020	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCCCCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495816	=	Activity	%	45.88	CHEMBL3023	Homo sapiens	Activity	%	45.88
	2634021	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495800	=	Activity	%	89.88	CHEMBL3023	Homo sapiens	Activity	%	89.88
	2634022	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495799	=	Activity	%	117.27	CHEMBL3023	Homo sapiens	Activity	%	117.27
	2634023	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL523732	=	Activity	%	126.29	CHEMBL3023	Homo sapiens	Activity	%	126.29
	2634024	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL495798	=	Activity	%	117.06	CHEMBL3023	Homo sapiens	Activity	%	117.06
	2634025	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL497627	=	Activity	%	62.81	CHEMBL3023	Homo sapiens	Activity	%	62.81
	2634026	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL524802	=	Activity	%	114.7	CHEMBL3023	Homo sapiens	Activity	%	114.7
	2634027	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCC#C[C@@H](O)[C@H](C)N		CHEMBL449946	=	Activity	%	95.71	CHEMBL3023	Homo sapiens	Activity	%	95.71
	2634028	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCCCCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL498023	=	Activity	%	152.49	CHEMBL3023	Homo sapiens	Activity	%	152.49
	2634029	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL498022	=	Activity	%	116.46	CHEMBL3023	Homo sapiens	Activity	%	116.46
	2634030	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL451259	=	Activity	%	108.86	CHEMBL3023	Homo sapiens	Activity	%	108.86
	2634031	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCC#C[C@H](O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL498021	=	Activity	%	111.03	CHEMBL3023	Homo sapiens	Activity	%	111.03
	2634032	CHEMBL995448	Effect on human cloned SPHK2 activity expressed in CHO cells at 10 uM relative to basal level	B	CCCCCCCCCCCCCC#C[C@@H](O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL527022	=	Activity	%	123.36	CHEMBL3023	Homo sapiens	Activity	%	123.36
	2634047	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	33.03	CHEMBL3023	Homo sapiens	INH	%	33.03
	2634048	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCCCCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495816	=	Inhibition	%	54.12	CHEMBL3023	Homo sapiens	INH	%	54.12
Not Active	2634049	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495800		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634050	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495799		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634051	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL523732		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634052	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL495798		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	2634053	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL497627	=	Inhibition	%	37.19	CHEMBL3023	Homo sapiens	INH	%	37.19
Not Active	2634054	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL524802		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	2634055	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCC#C[C@@H](O)[C@H](C)N		CHEMBL449946	=	Inhibition	%	4.29	CHEMBL3023	Homo sapiens	INH	%	4.29
Not Active	2634056	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCCCCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL498023		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634057	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL498022		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634058	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCC#C[C@@H](O)[C@@H](N)CO		CHEMBL451259		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634059	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCC#C[C@H](O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL498021		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2634060	CHEMBL995443	Inhibition of human cloned SPHK2 expressed in CHO cells at 10 uM	B	CCCCCCCCCCCCCC#C[C@@H](O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL527022		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	2634083	CHEMBL995452	Inhibition of human SPHK2 expressed in human U937 cells assessed as inhibition of endogenous sphingosine-1-phosphate levels at 5 uM after 2 hrs by ELISA	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333		Activity			CHEMBL3023	Homo sapiens	Activity		
Active	2634085	CHEMBL995452	Inhibition of human SPHK2 expressed in human U937 cells assessed as inhibition of endogenous sphingosine-1-phosphate levels at 5 uM after 2 hrs by ELISA	B	CCCCCCCCCCCCCC#CC(=O)[C@H](CO)NC(=O)OC(C)(C)C		CHEMBL495816		Activity			CHEMBL3023	Homo sapiens	Activity		
	2634090	CHEMBL995445	Inhibition of human cloned SPHK2 expressed in CHO cells using D-erythro-sphingosine as substrate by Michaelis-Menten plot	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Ki	nM	12500.0	CHEMBL3023	Homo sapiens	Ki	uM	12.5
	2644687	CHEMBL1032134	Inhibition of SphK2	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO		CHEMBL67166	=	IC50	nM	1560.0	CHEMBL3023	Homo sapiens	IC50	uM	1.56
	2644688	CHEMBL1032134	Inhibition of SphK2	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	>	IC50	nM	80000.0	CHEMBL3023	Homo sapiens	IC50	uM	80.0
	2644689	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCc1ccc(I)cc1		CHEMBL551092	=	IC50	nM	7230.0	CHEMBL3023	Homo sapiens	IC50	uM	7.23
	2644690	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCc1ccc(I)cc1		CHEMBL551232	=	IC50	nM	5730.0	CHEMBL3023	Homo sapiens	IC50	uM	5.73
	2644691	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCc1ccc(I)cc1		CHEMBL561025	=	IC50	nM	16600.0	CHEMBL3023	Homo sapiens	IC50	uM	16.6
	2644692	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCc1ccc(I)cc1		CHEMBL561296	=	IC50	nM	4380.0	CHEMBL3023	Homo sapiens	IC50	uM	4.38
	2644693	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCc1ccc(I)cc1		CHEMBL561434	=	IC50	nM	13300.0	CHEMBL3023	Homo sapiens	IC50	uM	13.3
	2644694	CHEMBL1032134	Inhibition of SphK2	B	N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCCc1ccc(I)cc1		CHEMBL559072	=	IC50	nM	29200.0	CHEMBL3023	Homo sapiens	IC50	uM	29.2
	2702966	CHEMBL1051863	Activity at human SPHK2 at 15 uM	B	CCCCCCCCc1ccc(-c2cnc([C@@](C)(N)CO)[nH]2)cc1		CHEMBL564090	=	Activity	%	20.0	CHEMBL3023	Homo sapiens	Activity	%	20.0
Not Active	2703031	CHEMBL1051864	Activity at human SPHK2 at 100 uM	B	CCCCCCCCc1ccc(-c2cnc([C@](C)(N)CO)[nH]2)cc1		CHEMBL538946		Activity			CHEMBL3023	Homo sapiens	Activity		
Not Active	2945671	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945672	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H](N)CO)cc1		CHEMBL575560		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945673	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)CO)cc1		CHEMBL572985		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945674	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)C(C)(N)CO)cc1		CHEMBL572912		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945675	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)COC)cc1		CHEMBL575356		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945676	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)C(N)C(C)(C)O)cc1		CHEMBL572723		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945677	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H](CO)NC)cc1		CHEMBL583709		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945678	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)[C@@H](C)O)cc1		CHEMBL427579		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945679	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H](N)[C@H](C)O)cc1		CHEMBL575748		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945680	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H](N)[C@@H](C)O)cc1		CHEMBL575959		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945681	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)[C@H](C)O)cc1		CHEMBL575960		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945682	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)[C@@H](O)CC)cc1		CHEMBL575137		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945683	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(CNC(=O)C(N)CO)cc1		CHEMBL584561		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945684	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC[C@@H](N)CO)cc1		CHEMBL572686		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945685	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H](N)CCO)cc1		CHEMBL572687		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945686	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCO)cc1		CHEMBL583979		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945687	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)C(N)CCO)cc1		CHEMBL575772		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945688	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)C(N)CCCO)cc1		CHEMBL574941		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945689	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCCCO)cc1		CHEMBL568698		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945690	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(CNC(=O)C(N)CCO)cc1		CHEMBL585551		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945691	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NCC(N)CCO)cc1		CHEMBL574237		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945692	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H]2NCC[C@@H]2O)cc1		CHEMBL574238		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945693	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H]2NCC[C@H]2O)cc1		CHEMBL575357		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945694	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC(=O)[C@H]2NC[C@@H](O)[C@@H]2O)cc1		CHEMBL575358		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945695	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(CNC(=O)[C@H]2NCC[C@@H]2O)cc1		CHEMBL572954		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945696	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(CCNC(=O)[C@H]2NCC[C@@H]2O)cc1		CHEMBL572955		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	2945697	CHEMBL1052797	Inhibition of sphingosine kinase 2 at 10 uM	B	CCCCCCCCc1ccc(NC[C@H]2NCC[C@@H]2O)cc1		CHEMBL578596		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	3252412	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1		CHEMBL314854	=	Activity	%	76.0	CHEMBL3023	Homo sapiens	Activity	%	76.0
	3252413	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@@H](C(N)(CO)CO)C2		CHEMBL1092111	=	Activity	%	9.0	CHEMBL3023	Homo sapiens	Activity	%	9.0
	3252414	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@H](C(N)(CO)CO)C2		CHEMBL1090707	=	Activity	%	3.0	CHEMBL3023	Homo sapiens	Activity	%	3.0
	3252415	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@H]([C@@](C)(N)CO)C2		CHEMBL1090708	=	Activity	%	77.0	CHEMBL3023	Homo sapiens	Activity	%	77.0
	3252416	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@@](C)(N)CO)C2		CHEMBL1091051	=	Activity	%	38.0	CHEMBL3023	Homo sapiens	Activity	%	38.0
	3252417	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@@H]([C@](C)(N)CO)C2		CHEMBL1091052	=	Activity	%	0.0	CHEMBL3023	Homo sapiens	Activity	%	0.0
	3252418	CHEMBL1110618	Induction of human SphK2 phosphorylation	B	CCCCCCCCc1ccc2c(c1)CC[C@H]([C@](C)(N)CO)C2		CHEMBL1091053	=	Activity	%	0.0	CHEMBL3023	Homo sapiens	Activity	%	0.0
Not Active	3596096	CHEMBL1291276	Inhibition of sphingosine kinase 2 up to 25 uM	B	COc1ccc(-c2cc(C(=O)N/N=C(\C)c3ccc(OC)c(OC)c3)[nH]n2)cc1		CHEMBL1289102		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	3596097	CHEMBL1291275	Inhibition of sphingosine kinase 2	B	O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc(-c2ccc3ccccc3c2)n[nH]1		CHEMBL1241832		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	6185466	CHEMBL1777262	Inhibition of SPHK2	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCO)cc1		CHEMBL583979	=	Ki	nM	31000.0	CHEMBL3023	Homo sapiens	Ki	uM	31.0
	6335513	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335525	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335539	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335553	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335555	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@H]1O		CHEMBL1819203	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335557	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@H]1O		CHEMBL1819202	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335559	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@H]1OC[C@H](N)[C@H]1O		CHEMBL466393	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335561	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@H]1O		CHEMBL466190	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	6335563	CHEMBL1821103	Inhibition of N-terminal GST-fused sphingosine kinase 2 (1-618) expressed in baculovirus expression system assessed as inhibition of sphingosine phosphorylation after 1 hr by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@H]1OC[C@H](N)[C@@H]1O		CHEMBL466394	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
Not Active	7976264	CHEMBL1929797	Inhibition of SphK2 in human U937 cells assessed as change in S1P level by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)C)CC2)cc1.[I-]		CHEMBL1927588		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	7976265	CHEMBL1929797	Inhibition of SphK2 in human U937 cells assessed as change in S1P level by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	7976266	CHEMBL1929798	Inhibition of SphK2 in human U937 cells using FTY720 as substrate assessed as decrease in phosphorylated FTY720 at 10 uM after 2 hrs by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)C)CC2)cc1.[I-]		CHEMBL1927588		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	7976267	CHEMBL1929799	Inhibition of SphK2 in human U937 cells using FTY720 as substrate assessed as accumulation of FTY720 at 10 uM after 2 hrs by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)C)CC2)cc1.[I-]		CHEMBL1927588		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	7976268	CHEMBL1929800	Inhibition of SphK2 in human U937 cells assessed as decrease in Akt phosphorylation after 16 hrs by Western blot analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)C)CC2)cc1.[I-]		CHEMBL1927588		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	7976269	CHEMBL1929801	Inhibition of SphK2 in human U937 cells assessed as decrease in ERK phosphorylation after 16 hrs by Western blot analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)C)CC2)cc1.[I-]		CHEMBL1927588		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	7976270	CHEMBL1929798	Inhibition of SphK2 in human U937 cells using FTY720 as substrate assessed as decrease in phosphorylated FTY720 at 10 uM after 2 hrs by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	7976271	CHEMBL1929799	Inhibition of SphK2 in human U937 cells using FTY720 as substrate assessed as accumulation of FTY720 at 10 uM after 2 hrs by LC/MS analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	7976272	CHEMBL1929800	Inhibition of SphK2 in human U937 cells assessed as decrease in Akt phosphorylation after 16 hrs by Western blot analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	7976273	CHEMBL1929801	Inhibition of SphK2 in human U937 cells assessed as decrease in ERK phosphorylation after 16 hrs by Western blot analysis	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	7976274	CHEMBL1929803	Inhibition of SphK2	B	CCCCCCCCc1ccc(CC[C@](N)(CO)OC)cc1		CHEMBL1927600	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	8061319	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8061496	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.11	CHEMBL3023	Homo sapiens	Inhibition	%	0.11
	8061827	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.78	CHEMBL3023	Homo sapiens	Inhibition	%	0.78
	8062018	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-4.3	CHEMBL3023	Homo sapiens	Inhibition	%	-4.3
	8062358	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.29	CHEMBL3023	Homo sapiens	Inhibition	%	2.29
	8062520	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.49	CHEMBL3023	Homo sapiens	Inhibition	%	1.49
	8062744	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8062842	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.26	CHEMBL3023	Homo sapiens	Inhibition	%	0.26
	8063198	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8063365	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.61	CHEMBL3023	Homo sapiens	Inhibition	%	-0.61
	8063697	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.17	CHEMBL3023	Homo sapiens	Inhibition	%	-0.17
	8063879	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.04	CHEMBL3023	Homo sapiens	Inhibition	%	-0.04
	8064103	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.13	CHEMBL3023	Homo sapiens	Inhibition	%	0.13
	8064218	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8064428	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8064652	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8064790	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.42	CHEMBL3023	Homo sapiens	Inhibition	%	-0.42
	8064956	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.61	CHEMBL3023	Homo sapiens	Inhibition	%	0.61
	8065180	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8065296	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.84	CHEMBL3023	Homo sapiens	Inhibition	%	-0.84
	8065695	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-0.65	CHEMBL3023	Homo sapiens	Inhibition	%	-0.65
	8065810	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8066244	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.28	CHEMBL3023	Homo sapiens	Inhibition	%	1.28
	8066380	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.4	CHEMBL3023	Homo sapiens	Inhibition	%	-0.4
	8066770	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.99	CHEMBL3023	Homo sapiens	Inhibition	%	1.99
	8066894	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.52	CHEMBL3023	Homo sapiens	Inhibition	%	0.52
	8067118	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8067293	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.31	CHEMBL3023	Homo sapiens	Inhibition	%	-0.31
	8067414	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.32	CHEMBL3023	Homo sapiens	Inhibition	%	2.32
	8067638	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.23	CHEMBL3023	Homo sapiens	Inhibition	%	0.23
	8067848	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.35	CHEMBL3023	Homo sapiens	Inhibition	%	1.35
	8067983	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8068207	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.21	CHEMBL3023	Homo sapiens	Inhibition	%	0.21
	8068371	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.09	CHEMBL3023	Homo sapiens	Inhibition	%	0.09
	8068720	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.33	CHEMBL3023	Homo sapiens	Inhibition	%	0.33
	8068894	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.98	CHEMBL3023	Homo sapiens	Inhibition	%	0.98
	8069243	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.19	CHEMBL3023	Homo sapiens	Inhibition	%	-0.19
	8069538	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	-0.1	CHEMBL3023	Homo sapiens	Inhibition	%	-0.1
	8069699	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-1.96	CHEMBL3023	Homo sapiens	Inhibition	%	-1.96
	8070049	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8070221	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-1.61	CHEMBL3023	Homo sapiens	Inhibition	%	-1.61
	8070570	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.31	CHEMBL3023	Homo sapiens	Inhibition	%	-0.31
	8070868	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	0.07	CHEMBL3023	Homo sapiens	Inhibition	%	0.07
	8071025	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8071249	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-2.78	CHEMBL3023	Homo sapiens	Inhibition	%	-2.78
	8071375	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.61	CHEMBL3023	Homo sapiens	Inhibition	%	0.61
	8071548	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-1.21	CHEMBL3023	Homo sapiens	Inhibition	%	-1.21
	8071772	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.57	CHEMBL3023	Homo sapiens	Inhibition	%	0.57
	8071897	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.09	CHEMBL3023	Homo sapiens	Inhibition	%	-1.09
	8072211	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8072592	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.28	CHEMBL3023	Homo sapiens	Inhibition	%	-0.28
	8072717	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.2	CHEMBL3023	Homo sapiens	Inhibition	%	0.2
	8073108	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.07	CHEMBL3023	Homo sapiens	Inhibition	%	0.07
	8073233	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.51	CHEMBL3023	Homo sapiens	Inhibition	%	0.51
	8073457	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.44	CHEMBL3023	Homo sapiens	Inhibition	%	-0.44
	8073576	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.19	CHEMBL3023	Homo sapiens	Inhibition	%	0.19
	8073809	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.65	CHEMBL3023	Homo sapiens	Inhibition	%	0.65
	8074033	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.01	CHEMBL3023	Homo sapiens	Inhibition	%	2.01
	8074185	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.5	CHEMBL3023	Homo sapiens	Inhibition	%	0.5
	8074315	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.13	CHEMBL3023	Homo sapiens	Inhibition	%	0.13
	8074539	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-2.18	CHEMBL3023	Homo sapiens	Inhibition	%	-2.18
	8074696	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8075047	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8075158	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.62	CHEMBL3023	Homo sapiens	Inhibition	%	0.62
	8075382	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.81	CHEMBL3023	Homo sapiens	Inhibition	%	-0.81
	8075619	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.13	CHEMBL3023	Homo sapiens	Inhibition	%	1.13
	8075760	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8076126	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8076274	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.42	CHEMBL3023	Homo sapiens	Inhibition	%	0.42
	8076632	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.78	CHEMBL3023	Homo sapiens	Inhibition	%	-0.78
	8076958	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8077205	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8077333	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.61	CHEMBL3023	Homo sapiens	Inhibition	%	0.61
	8077557	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8077708	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.97	CHEMBL3023	Homo sapiens	Inhibition	%	-2.97
	8077851	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-3.06	CHEMBL3023	Homo sapiens	Inhibition	%	-3.06
	8078075	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.29	CHEMBL3023	Homo sapiens	Inhibition	%	0.29
	8078214	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8078540	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.13	CHEMBL3023	Homo sapiens	Inhibition	%	0.13
	8078790	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.62	CHEMBL3023	Homo sapiens	Inhibition	%	-0.62
	8079130	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.55	CHEMBL3023	Homo sapiens	Inhibition	%	1.55
	8079288	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8079654	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8079793	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.11	CHEMBL3023	Homo sapiens	Inhibition	%	0.11
	8080122	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.91	CHEMBL3023	Homo sapiens	Inhibition	%	-0.91
	8080374	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8080713	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.06	CHEMBL3023	Homo sapiens	Inhibition	%	0.06
	8080877	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.27	CHEMBL3023	Homo sapiens	Inhibition	%	0.27
	8081236	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1	Outside typical range	CHEMBL1909391	=	Inhibition	%	-10.28	CHEMBL3023	Homo sapiens	Inhibition	%	-10.28
	8081380	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8081604	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8081707	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-1.48	CHEMBL3023	Homo sapiens	Inhibition	%	-1.48
	8081959	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.44	CHEMBL3023	Homo sapiens	Inhibition	%	-0.44
	8082183	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.2	CHEMBL3023	Homo sapiens	Inhibition	%	1.2
	8082296	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.29	CHEMBL3023	Homo sapiens	Inhibition	%	0.29
	8082469	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.57	CHEMBL3023	Homo sapiens	Inhibition	%	0.57
	8082693	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8082816	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.15	CHEMBL3023	Homo sapiens	Inhibition	%	0.15
	8083196	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.75	CHEMBL3023	Homo sapiens	Inhibition	%	0.75
	8083295	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.07	CHEMBL3023	Homo sapiens	Inhibition	%	-0.07
	8083519	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.0	CHEMBL3023	Homo sapiens	Inhibition	%	1.0
	8083773	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.21	CHEMBL3023	Homo sapiens	Inhibition	%	0.21
	8083883	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8084292	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8084410	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.32	CHEMBL3023	Homo sapiens	Inhibition	%	-0.32
	8084634	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8084795	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	-2.51	CHEMBL3023	Homo sapiens	Inhibition	%	-2.51
	8085117	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8085373	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.14	CHEMBL3023	Homo sapiens	Inhibition	%	2.14
	8085481	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-1.67	CHEMBL3023	Homo sapiens	Inhibition	%	-1.67
	8085705	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.42	CHEMBL3023	Homo sapiens	Inhibition	%	-0.42
	8085894	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.47	CHEMBL3023	Homo sapiens	Inhibition	%	7.47
	8086233	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-1.13	CHEMBL3023	Homo sapiens	Inhibition	%	-1.13
	8086395	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	0.67	CHEMBL3023	Homo sapiens	Inhibition	%	0.67
	8086718	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.06	CHEMBL3023	Homo sapiens	Inhibition	%	-1.06
	8086929	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.89	CHEMBL3023	Homo sapiens	Inhibition	%	0.89
	8087311	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8087425	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.93	CHEMBL3023	Homo sapiens	Inhibition	%	-0.93
	8087649	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.59	CHEMBL3023	Homo sapiens	Inhibition	%	-0.59
	8087787	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.36	CHEMBL3023	Homo sapiens	Inhibition	%	2.36
	8088153	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.77	CHEMBL3023	Homo sapiens	Inhibition	%	0.77
	8088301	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.04	CHEMBL3023	Homo sapiens	Inhibition	%	-0.04
	8088653	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-0.7	CHEMBL3023	Homo sapiens	Inhibition	%	-0.7
	8088970	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.24	CHEMBL3023	Homo sapiens	Inhibition	%	-0.24
	8089098	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8089470	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.66	CHEMBL3023	Homo sapiens	Inhibition	%	0.66
	8089590	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-2.23	CHEMBL3023	Homo sapiens	Inhibition	%	-2.23
	8089814	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8089994	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8090159	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.45	CHEMBL3023	Homo sapiens	Inhibition	%	-0.45
	8090383	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.67	CHEMBL3023	Homo sapiens	Inhibition	%	-0.67
	8090550	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-1.13	CHEMBL3023	Homo sapiens	Inhibition	%	-1.13
	8090689	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-1.13	CHEMBL3023	Homo sapiens	Inhibition	%	-1.13
	8090913	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.4	CHEMBL3023	Homo sapiens	Inhibition	%	-0.4
	8091118	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.85	CHEMBL3023	Homo sapiens	Inhibition	%	-0.85
	8091255	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-2.09	CHEMBL3023	Homo sapiens	Inhibition	%	-2.09
	8091479	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-1.02	CHEMBL3023	Homo sapiens	Inhibition	%	-1.02
	8091634	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.9	CHEMBL3023	Homo sapiens	Inhibition	%	0.9
	8091974	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.16	CHEMBL3023	Homo sapiens	Inhibition	%	-0.16
	8092111	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.51	CHEMBL3023	Homo sapiens	Inhibition	%	1.51
	8092486	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.27	CHEMBL3023	Homo sapiens	Inhibition	%	-0.27
	8092634	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.67	CHEMBL3023	Homo sapiens	Inhibition	%	-0.67
	8092858	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.31	CHEMBL3023	Homo sapiens	Inhibition	%	-2.31
	8092987	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8093299	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.62	CHEMBL3023	Homo sapiens	Inhibition	%	1.62
	8093439	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.09	CHEMBL3023	Homo sapiens	Inhibition	%	0.09
	8093663	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.25	CHEMBL3023	Homo sapiens	Inhibition	%	-1.25
	8093802	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.76	CHEMBL3023	Homo sapiens	Inhibition	%	0.76
	8094146	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.74	CHEMBL3023	Homo sapiens	Inhibition	%	-1.74
	8094326	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8094725	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-0.73	CHEMBL3023	Homo sapiens	Inhibition	%	-0.73
	8094881	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.14	CHEMBL3023	Homo sapiens	Inhibition	%	-0.14
	8095245	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.23	CHEMBL3023	Homo sapiens	Inhibition	%	1.23
	8095448	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8095813	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	0.04	CHEMBL3023	Homo sapiens	Inhibition	%	0.04
	8095961	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.07	CHEMBL3023	Homo sapiens	Inhibition	%	0.07
	8096302	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-0.49	CHEMBL3023	Homo sapiens	Inhibition	%	-0.49
	8096441	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.09	CHEMBL3023	Homo sapiens	Inhibition	%	1.09
	8096665	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.01	CHEMBL3023	Homo sapiens	Inhibition	%	0.01
	8096821	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.36	CHEMBL3023	Homo sapiens	Inhibition	%	0.36
	8097192	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.14	CHEMBL3023	Homo sapiens	Inhibition	%	1.14
	8097279	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.79	CHEMBL3023	Homo sapiens	Inhibition	%	0.79
	8097499	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-1.3	CHEMBL3023	Homo sapiens	Inhibition	%	-1.3
	8097873	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.35	CHEMBL3023	Homo sapiens	Inhibition	%	-2.35
	8098006	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.52	CHEMBL3023	Homo sapiens	Inhibition	%	0.52
	8098350	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.24	CHEMBL3023	Homo sapiens	Inhibition	%	-0.24
	8098530	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.61	CHEMBL3023	Homo sapiens	Inhibition	%	1.61
	8098754	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-2.53	CHEMBL3023	Homo sapiens	Inhibition	%	-2.53
	8098939	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-1.03	CHEMBL3023	Homo sapiens	Inhibition	%	-1.03
	8099083	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8099307	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-0.98	CHEMBL3023	Homo sapiens	Inhibition	%	-0.98
	8099449	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.29	CHEMBL3023	Homo sapiens	Inhibition	%	-0.29
	8099643	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.39	CHEMBL3023	Homo sapiens	Inhibition	%	-0.39
	8100014	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.29	CHEMBL3023	Homo sapiens	Inhibition	%	0.29
	8100160	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.14	CHEMBL3023	Homo sapiens	Inhibition	%	0.14
	8100384	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.12	CHEMBL3023	Homo sapiens	Inhibition	%	1.12
	8100500	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-0.15	CHEMBL3023	Homo sapiens	Inhibition	%	-0.15
	8100864	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.21	CHEMBL3023	Homo sapiens	Inhibition	%	2.21
	8101024	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.88	CHEMBL3023	Homo sapiens	Inhibition	%	0.88
	8101390	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.41	CHEMBL3023	Homo sapiens	Inhibition	%	1.41
	8101575	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8101828	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8102052	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-1.0	CHEMBL3023	Homo sapiens	Inhibition	%	-1.0
	8102207	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.9	CHEMBL3023	Homo sapiens	Inhibition	%	-0.9
	8102338	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8102562	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-1.48	CHEMBL3023	Homo sapiens	Inhibition	%	-1.48
	8102682	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.85	CHEMBL3023	Homo sapiens	Inhibition	%	-0.85
	8103084	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.35	CHEMBL3023	Homo sapiens	Inhibition	%	1.35
	8103280	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-0.49	CHEMBL3023	Homo sapiens	Inhibition	%	-0.49
	8103642	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8103792	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-1.72	CHEMBL3023	Homo sapiens	Inhibition	%	-1.72
	8103977	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.05	CHEMBL3023	Homo sapiens	Inhibition	%	0.05
	8104201	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8104349	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8104719	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.25	CHEMBL3023	Homo sapiens	Inhibition	%	-1.25
	8104833	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-1.27	CHEMBL3023	Homo sapiens	Inhibition	%	-1.27
	8105057	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.57	CHEMBL3023	Homo sapiens	Inhibition	%	-0.57
	8105197	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.2	CHEMBL3023	Homo sapiens	Inhibition	%	1.2
	8105363	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-0.67	CHEMBL3023	Homo sapiens	Inhibition	%	-0.67
	8105587	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.31	CHEMBL3023	Homo sapiens	Inhibition	%	-0.31
	8105725	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.15	CHEMBL3023	Homo sapiens	Inhibition	%	-0.15
	8106005	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.41	CHEMBL3023	Homo sapiens	Inhibition	%	-0.41
	8106394	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.03	CHEMBL3023	Homo sapiens	Inhibition	%	-0.03
	8106550	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.58	CHEMBL3023	Homo sapiens	Inhibition	%	0.58
	8106903	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.49	CHEMBL3023	Homo sapiens	Inhibition	%	0.49
	8107024	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.83	CHEMBL3023	Homo sapiens	Inhibition	%	-0.83
	8107248	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.59	CHEMBL3023	Homo sapiens	Inhibition	%	-0.59
	8107420	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.95	CHEMBL3023	Homo sapiens	Inhibition	%	-0.95
	8107621	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8107980	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.34	CHEMBL3023	Homo sapiens	Inhibition	%	0.34
	8108138	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-1.57	CHEMBL3023	Homo sapiens	Inhibition	%	-1.57
	8108537	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8108684	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl	Outside typical range	CHEMBL1794069	=	Inhibition	%	-11.33	CHEMBL3023	Homo sapiens	Inhibition	%	-11.33
	8109050	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.14	CHEMBL3023	Homo sapiens	Inhibition	%	0.14
	8109388	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.27	CHEMBL3023	Homo sapiens	Inhibition	%	0.27
	8109518	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8109913	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.96	CHEMBL3023	Homo sapiens	Inhibition	%	-1.96
	8110045	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-0.24	CHEMBL3023	Homo sapiens	Inhibition	%	-0.24
	8110269	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-0.57	CHEMBL3023	Homo sapiens	Inhibition	%	-0.57
	8110324	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-2.47	CHEMBL3023	Homo sapiens	Inhibition	%	-2.47
	8110714	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8110872	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.6	CHEMBL3023	Homo sapiens	Inhibition	%	0.6
	8111219	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-1.39	CHEMBL3023	Homo sapiens	Inhibition	%	-1.39
	8111570	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.65	CHEMBL3023	Homo sapiens	Inhibition	%	1.65
	8111736	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8111941	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.62	CHEMBL3023	Homo sapiens	Inhibition	%	0.62
	8112165	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-1.72	CHEMBL3023	Homo sapiens	Inhibition	%	-1.72
	8112302	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.03	CHEMBL3023	Homo sapiens	Inhibition	%	0.03
	8112470	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-1.5	CHEMBL3023	Homo sapiens	Inhibition	%	-1.5
	8112694	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-1.05	CHEMBL3023	Homo sapiens	Inhibition	%	-1.05
	8112866	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.37	CHEMBL3023	Homo sapiens	Inhibition	%	1.37
	8113018	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-0.12	CHEMBL3023	Homo sapiens	Inhibition	%	-0.12
	8113242	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.23	CHEMBL3023	Homo sapiens	Inhibition	%	0.23
	8113378	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	14.18	CHEMBL3023	Homo sapiens	Inhibition	%	14.18
	8113726	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.26	CHEMBL3023	Homo sapiens	Inhibition	%	0.26
	8113842	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.25	CHEMBL3023	Homo sapiens	Inhibition	%	0.25
	8114066	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.79	CHEMBL3023	Homo sapiens	Inhibition	%	0.79
	8114242	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.1	CHEMBL3023	Homo sapiens	Inhibition	%	0.1
	8114598	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-2.56	CHEMBL3023	Homo sapiens	Inhibition	%	-2.56
	8114650	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.91	CHEMBL3023	Homo sapiens	Inhibition	%	-0.91
	8114874	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-1.61	CHEMBL3023	Homo sapiens	Inhibition	%	-1.61
	8115040	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-1.33	CHEMBL3023	Homo sapiens	Inhibition	%	-1.33
	8115205	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.33	CHEMBL3023	Homo sapiens	Inhibition	%	-1.33
	8115429	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8115549	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-2.51	CHEMBL3023	Homo sapiens	Inhibition	%	-2.51
	8115906	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8116065	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.34	CHEMBL3023	Homo sapiens	Inhibition	%	0.34
	8116289	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.16	CHEMBL3023	Homo sapiens	Inhibition	%	0.16
	8116492	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-2.62	CHEMBL3023	Homo sapiens	Inhibition	%	-2.62
	8116626	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8117022	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.43	CHEMBL3023	Homo sapiens	Inhibition	%	0.43
	8117193	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.07	CHEMBL3023	Homo sapiens	Inhibition	%	1.07
	8117575	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.77	CHEMBL3023	Homo sapiens	Inhibition	%	3.77
	8117705	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.2	CHEMBL3023	Homo sapiens	Inhibition	%	1.2
	8117929	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.85	CHEMBL3023	Homo sapiens	Inhibition	%	-1.85
	8118067	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.4	CHEMBL3023	Homo sapiens	Inhibition	%	1.4
	8118407	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.78	CHEMBL3023	Homo sapiens	Inhibition	%	-0.78
	8118579	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.04	CHEMBL3023	Homo sapiens	Inhibition	%	0.04
	8118939	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.56	CHEMBL3023	Homo sapiens	Inhibition	%	-0.56
	8119210	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8119369	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	11.55	CHEMBL3023	Homo sapiens	Inhibition	%	11.55
	8119760	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8119879	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.49	CHEMBL3023	Homo sapiens	Inhibition	%	0.49
	8120103	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.93	CHEMBL3023	Homo sapiens	Inhibition	%	-0.93
	8120242	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.54	CHEMBL3023	Homo sapiens	Inhibition	%	-0.54
	8120626	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.71	CHEMBL3023	Homo sapiens	Inhibition	%	0.71
	8120827	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.82	CHEMBL3023	Homo sapiens	Inhibition	%	0.82
	8120955	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.61	CHEMBL3023	Homo sapiens	Inhibition	%	0.61
	8121179	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8121351	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.12	CHEMBL3023	Homo sapiens	Inhibition	%	-1.12
	8121518	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8121742	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-4.51	CHEMBL3023	Homo sapiens	Inhibition	%	-4.51
	8121905	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.77	CHEMBL3023	Homo sapiens	Inhibition	%	1.77
	8122250	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8122388	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.94	CHEMBL3023	Homo sapiens	Inhibition	%	-2.94
	8122732	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.28	CHEMBL3023	Homo sapiens	Inhibition	%	0.28
	8122899	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-1.23	CHEMBL3023	Homo sapiens	Inhibition	%	-1.23
	8123123	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.67	CHEMBL3023	Homo sapiens	Inhibition	%	0.67
	8123265	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.75	CHEMBL3023	Homo sapiens	Inhibition	%	0.75
	8123543	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.4	CHEMBL3023	Homo sapiens	Inhibition	%	-0.4
	8123693	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-0.52	CHEMBL3023	Homo sapiens	Inhibition	%	-0.52
	8123917	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-2.55	CHEMBL3023	Homo sapiens	Inhibition	%	-2.55
	8124084	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.58	CHEMBL3023	Homo sapiens	Inhibition	%	0.58
	8124427	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.58	CHEMBL3023	Homo sapiens	Inhibition	%	0.58
	8124566	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.85	CHEMBL3023	Homo sapiens	Inhibition	%	1.85
	8124955	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.03	CHEMBL3023	Homo sapiens	Inhibition	%	-0.03
	8125156	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.25	CHEMBL3023	Homo sapiens	Inhibition	%	1.25
	8125510	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8125678	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.6	CHEMBL3023	Homo sapiens	Inhibition	%	-1.6
	8126066	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.69	CHEMBL3023	Homo sapiens	Inhibition	%	-2.69
	8126230	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8126569	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8126705	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	-1.02	CHEMBL3023	Homo sapiens	Inhibition	%	-1.02
	8126929	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	-0.93	CHEMBL3023	Homo sapiens	Inhibition	%	-0.93
	8127051	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.41	CHEMBL3023	Homo sapiens	Inhibition	%	-0.41
	8127442	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	-0.46	CHEMBL3023	Homo sapiens	Inhibition	%	-0.46
	8127584	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.0	CHEMBL3023	Homo sapiens	Inhibition	%	-2.0
	8127872	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.82	CHEMBL3023	Homo sapiens	Inhibition	%	0.82
	8128248	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.12	CHEMBL3023	Homo sapiens	Inhibition	%	-0.12
	8128415	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8128758	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.48	CHEMBL3023	Homo sapiens	Inhibition	%	-1.48
	8128895	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-2.47	CHEMBL3023	Homo sapiens	Inhibition	%	-2.47
	8129119	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.43	CHEMBL3023	Homo sapiens	Inhibition	%	1.43
	8129290	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.68	CHEMBL3023	Homo sapiens	Inhibition	%	-0.68
	8129479	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.72	CHEMBL3023	Homo sapiens	Inhibition	%	0.72
	8129703	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8129842	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.77	CHEMBL3023	Homo sapiens	Inhibition	%	-1.77
	8130003	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.21	CHEMBL3023	Homo sapiens	Inhibition	%	-1.21
	8130227	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-4.21	CHEMBL3023	Homo sapiens	Inhibition	%	-4.21
	8130399	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.5	CHEMBL3023	Homo sapiens	Inhibition	%	-1.5
	8130559	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.29	CHEMBL3023	Homo sapiens	Inhibition	%	4.29
	8130783	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.72	CHEMBL3023	Homo sapiens	Inhibition	%	2.72
	8130899	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.29	CHEMBL3023	Homo sapiens	Inhibition	%	0.29
	8131262	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-0.64	CHEMBL3023	Homo sapiens	Inhibition	%	-0.64
	8131382	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.56	CHEMBL3023	Homo sapiens	Inhibition	%	-0.56
	8131606	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.08	CHEMBL3023	Homo sapiens	Inhibition	%	-1.08
	8131773	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8131914	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.27	CHEMBL3023	Homo sapiens	Inhibition	%	0.27
	8132138	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.95	CHEMBL3023	Homo sapiens	Inhibition	%	1.95
	8132200	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8132424	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.91	CHEMBL3023	Homo sapiens	Inhibition	%	0.91
	8132571	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.05	CHEMBL3023	Homo sapiens	Inhibition	%	0.05
	8132739	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.11	CHEMBL3023	Homo sapiens	Inhibition	%	0.11
	8132963	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.01	CHEMBL3023	Homo sapiens	Inhibition	%	-0.01
	8133084	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8133446	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-1.05	CHEMBL3023	Homo sapiens	Inhibition	%	-1.05
	8133618	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.96	CHEMBL3023	Homo sapiens	Inhibition	%	0.96
	8134022	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.74	CHEMBL3023	Homo sapiens	Inhibition	%	-0.74
	8134170	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.92	CHEMBL3023	Homo sapiens	Inhibition	%	0.92
	8134554	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.42	CHEMBL3023	Homo sapiens	Inhibition	%	0.42
	8134738	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.15	CHEMBL3023	Homo sapiens	Inhibition	%	-1.15
	8135122	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8135237	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.56	CHEMBL3023	Homo sapiens	Inhibition	%	4.56
	8135602	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.85	CHEMBL3023	Homo sapiens	Inhibition	%	0.85
	8135947	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.86	CHEMBL3023	Homo sapiens	Inhibition	%	-1.86
	8136115	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.71	CHEMBL3023	Homo sapiens	Inhibition	%	-0.71
	8136483	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-0.59	CHEMBL3023	Homo sapiens	Inhibition	%	-0.59
	8136773	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.35	CHEMBL3023	Homo sapiens	Inhibition	%	-0.35
	8136908	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8137295	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-0.44	CHEMBL3023	Homo sapiens	Inhibition	%	-0.44
	8137415	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8137639	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.8	CHEMBL3023	Homo sapiens	Inhibition	%	0.8
	8137787	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8137953	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.4	CHEMBL3023	Homo sapiens	Inhibition	%	0.4
	8138177	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.81	CHEMBL3023	Homo sapiens	Inhibition	%	-1.81
	8138356	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.09	CHEMBL3023	Homo sapiens	Inhibition	%	0.09
	8138504	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.08	CHEMBL3023	Homo sapiens	Inhibition	%	-0.08
	8138728	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.05	CHEMBL3023	Homo sapiens	Inhibition	%	-1.05
	8138886	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.05	CHEMBL3023	Homo sapiens	Inhibition	%	-0.05
	8139071	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.65	CHEMBL3023	Homo sapiens	Inhibition	%	0.65
	8139454	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8139568	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-1.22	CHEMBL3023	Homo sapiens	Inhibition	%	-1.22
	8139792	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.8	CHEMBL3023	Homo sapiens	Inhibition	%	0.8
	8139933	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.71	CHEMBL3023	Homo sapiens	Inhibition	%	4.71
	8140280	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.97	CHEMBL3023	Homo sapiens	Inhibition	%	-0.97
	8140439	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.63	CHEMBL3023	Homo sapiens	Inhibition	%	-0.63
	8140806	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8141108	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8141238	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-1.45	CHEMBL3023	Homo sapiens	Inhibition	%	-1.45
	8141462	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.87	CHEMBL3023	Homo sapiens	Inhibition	%	0.87
	8141622	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.31	CHEMBL3023	Homo sapiens	Inhibition	%	1.31
	8141965	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.92	CHEMBL3023	Homo sapiens	Inhibition	%	2.92
	8142126	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.07	CHEMBL3023	Homo sapiens	Inhibition	%	-0.07
	8142518	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.47	CHEMBL3023	Homo sapiens	Inhibition	%	-2.47
	8142694	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.46	CHEMBL3023	Homo sapiens	Inhibition	%	-0.46
	8143067	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.77	CHEMBL3023	Homo sapiens	Inhibition	%	1.77
	8143222	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-3.76	CHEMBL3023	Homo sapiens	Inhibition	%	-3.76
	8143409	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.66	CHEMBL3023	Homo sapiens	Inhibition	%	-0.66
	8143633	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.26	CHEMBL3023	Homo sapiens	Inhibition	%	3.26
	8143792	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8144130	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8144269	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.73	CHEMBL3023	Homo sapiens	Inhibition	%	0.73
	8144493	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8144623	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.93	CHEMBL3023	Homo sapiens	Inhibition	%	-0.93
	8144776	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.5	CHEMBL3023	Homo sapiens	Inhibition	%	-0.5
	8145000	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.63	CHEMBL3023	Homo sapiens	Inhibition	%	-0.63
	8145137	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-0.55	CHEMBL3023	Homo sapiens	Inhibition	%	-0.55
	8145450	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.81	CHEMBL3023	Homo sapiens	Inhibition	%	0.81
	8145798	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8145959	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.77	CHEMBL3023	Homo sapiens	Inhibition	%	0.77
	8146303	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.54	CHEMBL3023	Homo sapiens	Inhibition	%	-0.54
	8146463	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.39	CHEMBL3023	Homo sapiens	Inhibition	%	0.39
	8146687	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.92	CHEMBL3023	Homo sapiens	Inhibition	%	4.92
	8146854	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.08	CHEMBL3023	Homo sapiens	Inhibition	%	-0.08
	8147023	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.32	CHEMBL3023	Homo sapiens	Inhibition	%	1.32
	8147389	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-1.01	CHEMBL3023	Homo sapiens	Inhibition	%	-1.01
	8147542	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8147766	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-1.04	CHEMBL3023	Homo sapiens	Inhibition	%	-1.04
	8147953	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.52	CHEMBL3023	Homo sapiens	Inhibition	%	-0.52
	8148111	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8148449	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.58	CHEMBL3023	Homo sapiens	Inhibition	%	-1.58
	8148812	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.76	CHEMBL3023	Homo sapiens	Inhibition	%	2.76
	8148950	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.71	CHEMBL3023	Homo sapiens	Inhibition	%	0.71
	8149333	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8149467	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.69	CHEMBL3023	Homo sapiens	Inhibition	%	0.69
	8149691	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8149789	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.57	CHEMBL3023	Homo sapiens	Inhibition	%	0.57
	8150138	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.7	CHEMBL3023	Homo sapiens	Inhibition	%	0.7
	8150298	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.82	CHEMBL3023	Homo sapiens	Inhibition	%	-0.82
	8150522	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.55	CHEMBL3023	Homo sapiens	Inhibition	%	0.55
	8150642	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.1	CHEMBL3023	Homo sapiens	Inhibition	%	-0.1
	8151031	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.26	CHEMBL3023	Homo sapiens	Inhibition	%	-0.26
	8151194	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.1	CHEMBL3023	Homo sapiens	Inhibition	%	-1.1
	8151371	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8151595	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8151733	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.56	CHEMBL3023	Homo sapiens	Inhibition	%	-0.56
	8152111	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.08	CHEMBL3023	Homo sapiens	Inhibition	%	-0.08
	8152299	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.45	CHEMBL3023	Homo sapiens	Inhibition	%	-0.45
	8152457	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.84	CHEMBL3023	Homo sapiens	Inhibition	%	0.84
	8152681	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.14	CHEMBL3023	Homo sapiens	Inhibition	%	7.14
	8152795	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.07	CHEMBL3023	Homo sapiens	Inhibition	%	-0.07
	8153158	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.42	CHEMBL3023	Homo sapiens	Inhibition	%	0.42
	8153295	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.08	CHEMBL3023	Homo sapiens	Inhibition	%	0.08
	8153519	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.81	CHEMBL3023	Homo sapiens	Inhibition	%	2.81
	8153676	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.75	CHEMBL3023	Homo sapiens	Inhibition	%	-0.75
	8154033	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	8.93	CHEMBL3023	Homo sapiens	Inhibition	%	8.93
	8154130	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	19.7	CHEMBL3023	Homo sapiens	Inhibition	%	19.7
	8154354	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	13.14	CHEMBL3023	Homo sapiens	Inhibition	%	13.14
	8154480	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.32	CHEMBL3023	Homo sapiens	Inhibition	%	-0.32
	8154863	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-7.19	CHEMBL3023	Homo sapiens	Inhibition	%	-7.19
	8154983	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.56	CHEMBL3023	Homo sapiens	Inhibition	%	3.56
	8155383	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.68	CHEMBL3023	Homo sapiens	Inhibition	%	-0.68
	8155544	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.65	CHEMBL3023	Homo sapiens	Inhibition	%	0.65
	8155946	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.3	CHEMBL3023	Homo sapiens	Inhibition	%	0.3
	8156084	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.38	CHEMBL3023	Homo sapiens	Inhibition	%	2.38
	8156520	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-0.23	CHEMBL3023	Homo sapiens	Inhibition	%	-0.23
	8156670	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.73	CHEMBL3023	Homo sapiens	Inhibition	%	0.73
	8157037	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-1.09	CHEMBL3023	Homo sapiens	Inhibition	%	-1.09
	8157157	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8157381	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-2.04	CHEMBL3023	Homo sapiens	Inhibition	%	-2.04
	8157522	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.44	CHEMBL3023	Homo sapiens	Inhibition	%	0.44
	8157876	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	0.43	CHEMBL3023	Homo sapiens	Inhibition	%	0.43
	8158037	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.88	CHEMBL3023	Homo sapiens	Inhibition	%	-0.88
	8158287	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.01	CHEMBL3023	Homo sapiens	Inhibition	%	4.01
	8158669	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.47	CHEMBL3023	Homo sapiens	Inhibition	%	-0.47
	8158838	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.23	CHEMBL3023	Homo sapiens	Inhibition	%	2.23
	8159197	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.46	CHEMBL3023	Homo sapiens	Inhibition	%	0.46
	8159541	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.08	CHEMBL3023	Homo sapiens	Inhibition	%	0.08
	8159672	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	-0.8	CHEMBL3023	Homo sapiens	Inhibition	%	-0.8
	8160037	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8160174	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.39	CHEMBL3023	Homo sapiens	Inhibition	%	1.39
	8160398	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-0.6	CHEMBL3023	Homo sapiens	Inhibition	%	-0.6
	8160548	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.29	CHEMBL3023	Homo sapiens	Inhibition	%	2.29
	8160842	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-0.24	CHEMBL3023	Homo sapiens	Inhibition	%	-0.24
	8160992	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.36	CHEMBL3023	Homo sapiens	Inhibition	%	0.36
	8161216	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.38	CHEMBL3023	Homo sapiens	Inhibition	%	0.38
	8161359	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.07	CHEMBL3023	Homo sapiens	Inhibition	%	2.07
	8161708	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.69	CHEMBL3023	Homo sapiens	Inhibition	%	0.69
	8161846	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-3.1	CHEMBL3023	Homo sapiens	Inhibition	%	-3.1
	8162200	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.28	CHEMBL3023	Homo sapiens	Inhibition	%	1.28
	8162360	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.2	CHEMBL3023	Homo sapiens	Inhibition	%	-0.2
	8162584	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.28	CHEMBL3023	Homo sapiens	Inhibition	%	-0.28
	8162613	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.23	CHEMBL3023	Homo sapiens	Inhibition	%	0.23
	8162837	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.8	CHEMBL3023	Homo sapiens	Inhibition	%	-0.8
	8162985	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	1.68	CHEMBL3023	Homo sapiens	Inhibition	%	1.68
	8163154	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.13	CHEMBL3023	Homo sapiens	Inhibition	%	0.13
	8163378	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8163512	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-2.18	CHEMBL3023	Homo sapiens	Inhibition	%	-2.18
	8163859	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.64	CHEMBL3023	Homo sapiens	Inhibition	%	0.64
	8163993	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.62	CHEMBL3023	Homo sapiens	Inhibition	%	1.62
	8164217	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	-1.24	CHEMBL3023	Homo sapiens	Inhibition	%	-1.24
	8164357	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.82	CHEMBL3023	Homo sapiens	Inhibition	%	3.82
	8164736	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8164880	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.26	CHEMBL3023	Homo sapiens	Inhibition	%	0.26
	8165174	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8165539	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.55	CHEMBL3023	Homo sapiens	Inhibition	%	-0.55
	8165682	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	0.2	CHEMBL3023	Homo sapiens	Inhibition	%	0.2
	8166032	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8166170	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.87	CHEMBL3023	Homo sapiens	Inhibition	%	0.87
	8166394	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8166524	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8166849	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.88	CHEMBL3023	Homo sapiens	Inhibition	%	0.88
	8167161	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.73	CHEMBL3023	Homo sapiens	Inhibition	%	0.73
	8167302	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.35	CHEMBL3023	Homo sapiens	Inhibition	%	2.35
	8167690	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.03	CHEMBL3023	Homo sapiens	Inhibition	%	0.03
	8167823	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.46	CHEMBL3023	Homo sapiens	Inhibition	%	3.46
	8168047	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-5.33	CHEMBL3023	Homo sapiens	Inhibition	%	-5.33
	8168171	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8168536	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.78	CHEMBL3023	Homo sapiens	Inhibition	%	0.78
	8168672	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.43	CHEMBL3023	Homo sapiens	Inhibition	%	-2.43
	8169060	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	-6.48	CHEMBL3023	Homo sapiens	Inhibition	%	-6.48
	8169202	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.2	CHEMBL3023	Homo sapiens	Inhibition	%	1.2
	8169426	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8169506	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-1.01	CHEMBL3023	Homo sapiens	Inhibition	%	-1.01
	8169864	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-2.0	CHEMBL3023	Homo sapiens	Inhibition	%	-2.0
	8170009	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.12	CHEMBL3023	Homo sapiens	Inhibition	%	1.12
	8170233	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8170358	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8170722	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.73	CHEMBL3023	Homo sapiens	Inhibition	%	1.73
	8170857	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-1.65	CHEMBL3023	Homo sapiens	Inhibition	%	-1.65
	8171278	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-1.28	CHEMBL3023	Homo sapiens	Inhibition	%	-1.28
	8171495	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.35	CHEMBL3023	Homo sapiens	Inhibition	%	-0.35
	8171636	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8171860	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	-2.8	CHEMBL3023	Homo sapiens	Inhibition	%	-2.8
	8172013	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.58	CHEMBL3023	Homo sapiens	Inhibition	%	3.58
	8172369	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-0.03	CHEMBL3023	Homo sapiens	Inhibition	%	-0.03
	8172497	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.16	CHEMBL3023	Homo sapiens	Inhibition	%	-0.16
	8172863	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	-0.19	CHEMBL3023	Homo sapiens	Inhibition	%	-0.19
	8172999	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.74	CHEMBL3023	Homo sapiens	Inhibition	%	0.74
	8173223	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.18	CHEMBL3023	Homo sapiens	Inhibition	%	-0.18
	8173388	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	-0.91	CHEMBL3023	Homo sapiens	Inhibition	%	-0.91
	8173753	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.41	CHEMBL3023	Homo sapiens	Inhibition	%	0.41
	8173840	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.57	CHEMBL3023	Homo sapiens	Inhibition	%	1.57
	8174064	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	0.18	CHEMBL3023	Homo sapiens	Inhibition	%	0.18
	8174196	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.39	CHEMBL3023	Homo sapiens	Inhibition	%	-0.39
	8174568	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8174690	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.27	CHEMBL3023	Homo sapiens	Inhibition	%	0.27
	8175057	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.73	CHEMBL3023	Homo sapiens	Inhibition	%	-2.73
	8175193	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.26	CHEMBL3023	Homo sapiens	Inhibition	%	0.26
	8175417	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.48	CHEMBL3023	Homo sapiens	Inhibition	%	-0.48
	8175673	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.3	CHEMBL3023	Homo sapiens	Inhibition	%	1.3
	8175836	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.44	CHEMBL3023	Homo sapiens	Inhibition	%	0.44
	8176213	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	0.05	CHEMBL3023	Homo sapiens	Inhibition	%	0.05
	8176362	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8176718	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-2.68	CHEMBL3023	Homo sapiens	Inhibition	%	-2.68
	8176848	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.27	CHEMBL3023	Homo sapiens	Inhibition	%	-0.27
	8177072	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.04	CHEMBL3023	Homo sapiens	Inhibition	%	0.04
	8177214	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.53	CHEMBL3023	Homo sapiens	Inhibition	%	1.53
	8177576	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-2.46	CHEMBL3023	Homo sapiens	Inhibition	%	-2.46
	8177740	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	-0.32	CHEMBL3023	Homo sapiens	Inhibition	%	-0.32
	8178104	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-1.79	CHEMBL3023	Homo sapiens	Inhibition	%	-1.79
	8178416	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.26	CHEMBL3023	Homo sapiens	Inhibition	%	-0.26
	8178543	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.47	CHEMBL3023	Homo sapiens	Inhibition	%	-0.47
	8178916	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.28	CHEMBL3023	Homo sapiens	Inhibition	%	1.28
	8179039	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.52	CHEMBL3023	Homo sapiens	Inhibition	%	0.52
	8179263	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-3.06	CHEMBL3023	Homo sapiens	Inhibition	%	-3.06
	8179407	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.9	CHEMBL3023	Homo sapiens	Inhibition	%	2.9
	8179768	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.75	CHEMBL3023	Homo sapiens	Inhibition	%	0.75
	8180025	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-0.94	CHEMBL3023	Homo sapiens	Inhibition	%	-0.94
	8180179	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.14	CHEMBL3023	Homo sapiens	Inhibition	%	0.14
	8180403	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.87	CHEMBL3023	Homo sapiens	Inhibition	%	0.87
	8180559	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	-0.74	CHEMBL3023	Homo sapiens	Inhibition	%	-0.74
	8180707	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.7	CHEMBL3023	Homo sapiens	Inhibition	%	0.7
	8180931	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.06	CHEMBL3023	Homo sapiens	Inhibition	%	0.06
	8181064	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.04	CHEMBL3023	Homo sapiens	Inhibition	%	1.04
	8181419	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8181559	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8181783	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-1.1	CHEMBL3023	Homo sapiens	Inhibition	%	-1.1
	8181922	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-0.32	CHEMBL3023	Homo sapiens	Inhibition	%	-0.32
	8182085	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-1.13	CHEMBL3023	Homo sapiens	Inhibition	%	-1.13
	8182309	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-1.05	CHEMBL3023	Homo sapiens	Inhibition	%	-1.05
	8182449	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.99	CHEMBL3023	Homo sapiens	Inhibition	%	-0.99
	8182765	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.69	CHEMBL3023	Homo sapiens	Inhibition	%	0.69
	8182887	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-1.23	CHEMBL3023	Homo sapiens	Inhibition	%	-1.23
	8183111	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.38	CHEMBL3023	Homo sapiens	Inhibition	%	0.38
	8183260	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8183613	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.37	CHEMBL3023	Homo sapiens	Inhibition	%	3.37
	8183755	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-0.04	CHEMBL3023	Homo sapiens	Inhibition	%	-0.04
	8183979	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8184115	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.76	CHEMBL3023	Homo sapiens	Inhibition	%	0.76
	8184381	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-2.16	CHEMBL3023	Homo sapiens	Inhibition	%	-2.16
	8184752	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.25	CHEMBL3023	Homo sapiens	Inhibition	%	-0.25
	8184909	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8185282	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8185413	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.77	CHEMBL3023	Homo sapiens	Inhibition	%	1.77
	8185768	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.53	CHEMBL3023	Homo sapiens	Inhibition	%	0.53
	8186131	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-0.92	CHEMBL3023	Homo sapiens	Inhibition	%	-0.92
	8186272	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.2	CHEMBL3023	Homo sapiens	Inhibition	%	5.2
	8186660	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.83	CHEMBL3023	Homo sapiens	Inhibition	%	0.83
	8186799	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8187121	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.32	CHEMBL3023	Homo sapiens	Inhibition	%	0.32
	8187469	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.81	CHEMBL3023	Homo sapiens	Inhibition	%	1.81
	8187617	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-2.0	CHEMBL3023	Homo sapiens	Inhibition	%	-2.0
	8187841	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.98	CHEMBL3023	Homo sapiens	Inhibition	%	0.98
	8187970	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.75	CHEMBL3023	Homo sapiens	Inhibition	%	4.75
	8188337	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-3.44	CHEMBL3023	Homo sapiens	Inhibition	%	-3.44
	8188472	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.7	CHEMBL3023	Homo sapiens	Inhibition	%	2.7
	8188746	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.46	CHEMBL3023	Homo sapiens	Inhibition	%	-0.46
	8189118	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-1.04	CHEMBL3023	Homo sapiens	Inhibition	%	-1.04
	8189274	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.35	CHEMBL3023	Homo sapiens	Inhibition	%	0.35
	8189498	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.81	CHEMBL3023	Homo sapiens	Inhibition	%	0.81
	8189647	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.39	CHEMBL3023	Homo sapiens	Inhibition	%	-2.39
	8189779	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.09	CHEMBL3023	Homo sapiens	Inhibition	%	-0.09
	8190003	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.04	CHEMBL3023	Homo sapiens	Inhibition	%	0.04
	8190135	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.31	CHEMBL3023	Homo sapiens	Inhibition	%	2.31
	8190499	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8190636	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8190860	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.37	CHEMBL3023	Homo sapiens	Inhibition	%	0.37
	8191024	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.21	CHEMBL3023	Homo sapiens	Inhibition	%	0.21
	8191162	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8191386	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.33	CHEMBL3023	Homo sapiens	Inhibition	%	2.33
	8191482	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.47	CHEMBL3023	Homo sapiens	Inhibition	%	0.47
	8191828	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-2.35	CHEMBL3023	Homo sapiens	Inhibition	%	-2.35
	8192201	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.95	CHEMBL3023	Homo sapiens	Inhibition	%	1.95
	8192330	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.04	CHEMBL3023	Homo sapiens	Inhibition	%	1.04
	8192698	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8192834	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.05	CHEMBL3023	Homo sapiens	Inhibition	%	-2.05
	8193058	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.25	CHEMBL3023	Homo sapiens	Inhibition	%	4.25
	8193106	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.62	CHEMBL3023	Homo sapiens	Inhibition	%	-0.62
	8193330	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.03	CHEMBL3023	Homo sapiens	Inhibition	%	1.03
	8193475	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.89	CHEMBL3023	Homo sapiens	Inhibition	%	1.89
	8193856	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.83	CHEMBL3023	Homo sapiens	Inhibition	%	0.83
	8194005	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.74	CHEMBL3023	Homo sapiens	Inhibition	%	0.74
	8194360	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	-0.83	CHEMBL3023	Homo sapiens	Inhibition	%	-0.83
	8194491	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.1	CHEMBL3023	Homo sapiens	Inhibition	%	0.1
	8194715	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.69	CHEMBL3023	Homo sapiens	Inhibition	%	0.69
	8194858	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-1.58	CHEMBL3023	Homo sapiens	Inhibition	%	-1.58
	8195215	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-1.92	CHEMBL3023	Homo sapiens	Inhibition	%	-1.92
	8195379	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.43	CHEMBL3023	Homo sapiens	Inhibition	%	1.43
	8195742	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8195840	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8196064	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-2.07	CHEMBL3023	Homo sapiens	Inhibition	%	-2.07
	8196181	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.11	CHEMBL3023	Homo sapiens	Inhibition	%	0.11
	8196555	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-1.64	CHEMBL3023	Homo sapiens	Inhibition	%	-1.64
	8196683	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.14	CHEMBL3023	Homo sapiens	Inhibition	%	0.14
	8196907	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.11	CHEMBL3023	Homo sapiens	Inhibition	%	0.11
	8197048	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8197409	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8197684	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.1	CHEMBL3023	Homo sapiens	Inhibition	%	-1.1
	8197824	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	5.21	CHEMBL3023	Homo sapiens	Inhibition	%	5.21
	8198205	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.14	CHEMBL3023	Homo sapiens	Inhibition	%	-0.14
	8198343	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.77	CHEMBL3023	Homo sapiens	Inhibition	%	-0.77
	8198567	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.74	CHEMBL3023	Homo sapiens	Inhibition	%	-0.74
	8198697	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.12	CHEMBL3023	Homo sapiens	Inhibition	%	0.12
	8199052	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.87	CHEMBL3023	Homo sapiens	Inhibition	%	0.87
	8199200	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-0.89	CHEMBL3023	Homo sapiens	Inhibition	%	-0.89
	8199558	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-1.37	CHEMBL3023	Homo sapiens	Inhibition	%	-1.37
	8199721	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.2	CHEMBL3023	Homo sapiens	Inhibition	%	1.2
	8199945	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.51	CHEMBL3023	Homo sapiens	Inhibition	%	0.51
	8200083	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.5	CHEMBL3023	Homo sapiens	Inhibition	%	0.5
	8200411	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.19	CHEMBL3023	Homo sapiens	Inhibition	%	-0.19
	8200526	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.64	CHEMBL3023	Homo sapiens	Inhibition	%	-0.64
	8200750	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.06	CHEMBL3023	Homo sapiens	Inhibition	%	0.06
	8200900	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8201254	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8201389	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.23	CHEMBL3023	Homo sapiens	Inhibition	%	-0.23
	8201746	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.43	CHEMBL3023	Homo sapiens	Inhibition	%	0.43
	8202025	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.03	CHEMBL3023	Homo sapiens	Inhibition	%	0.03
	8202165	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-4.96	CHEMBL3023	Homo sapiens	Inhibition	%	-4.96
	8202389	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.01	CHEMBL3023	Homo sapiens	Inhibition	%	-0.01
	8202556	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.18	CHEMBL3023	Homo sapiens	Inhibition	%	-0.18
	8202905	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.12	CHEMBL3023	Homo sapiens	Inhibition	%	-0.12
	8203035	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8203390	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.17	CHEMBL3023	Homo sapiens	Inhibition	%	-0.17
	8203536	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-0.82	CHEMBL3023	Homo sapiens	Inhibition	%	-0.82
	8203760	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.35	CHEMBL3023	Homo sapiens	Inhibition	%	2.35
	8203894	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.98	CHEMBL3023	Homo sapiens	Inhibition	%	0.98
	8204284	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8204421	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.62	CHEMBL3023	Homo sapiens	Inhibition	%	0.62
	8204750	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.98	CHEMBL3023	Homo sapiens	Inhibition	%	0.98
	8205089	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.42	CHEMBL3023	Homo sapiens	Inhibition	%	0.42
	8205238	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8205598	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8205737	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.0	CHEMBL3023	Homo sapiens	Inhibition	%	1.0
	8205961	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.51	CHEMBL3023	Homo sapiens	Inhibition	%	0.51
	8206093	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.76	CHEMBL3023	Homo sapiens	Inhibition	%	0.76
	8206369	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.79	CHEMBL3023	Homo sapiens	Inhibition	%	0.79
	8206736	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8206916	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.92	CHEMBL3023	Homo sapiens	Inhibition	%	0.92
	8207266	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.78	CHEMBL3023	Homo sapiens	Inhibition	%	0.78
	8207396	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-2.23	CHEMBL3023	Homo sapiens	Inhibition	%	-2.23
	8207620	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-0.76	CHEMBL3023	Homo sapiens	Inhibition	%	-0.76
	8207752	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8208121	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8208253	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-1.45	CHEMBL3023	Homo sapiens	Inhibition	%	-1.45
	8208477	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-1.01	CHEMBL3023	Homo sapiens	Inhibition	%	-1.01
	8208643	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.52	CHEMBL3023	Homo sapiens	Inhibition	%	0.52
	8208776	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-0.19	CHEMBL3023	Homo sapiens	Inhibition	%	-0.19
	8209000	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.27	CHEMBL3023	Homo sapiens	Inhibition	%	0.27
	8209105	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.06	CHEMBL3023	Homo sapiens	Inhibition	%	0.06
	8209445	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.63	CHEMBL3023	Homo sapiens	Inhibition	%	-0.63
	8209595	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.66	CHEMBL3023	Homo sapiens	Inhibition	%	1.66
	8209819	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.08	CHEMBL3023	Homo sapiens	Inhibition	%	0.08
	8209955	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.06	CHEMBL3023	Homo sapiens	Inhibition	%	0.06
	8210320	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.13	CHEMBL3023	Homo sapiens	Inhibition	%	-0.13
	8210456	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.06	CHEMBL3023	Homo sapiens	Inhibition	%	-0.06
	8210715	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.02	CHEMBL3023	Homo sapiens	Inhibition	%	0.02
	8210939	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.44	CHEMBL3023	Homo sapiens	Inhibition	%	0.44
	8211083	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.14	CHEMBL3023	Homo sapiens	Inhibition	%	0.14
	8211253	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.09	CHEMBL3023	Homo sapiens	Inhibition	%	0.09
	8211477	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	Inhibition	%	0.0
	8211600	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.1	CHEMBL3023	Homo sapiens	Inhibition	%	0.1
	8211953	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-0.74	CHEMBL3023	Homo sapiens	Inhibition	%	-0.74
	8212085	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	-1.2	CHEMBL3023	Homo sapiens	Inhibition	%	-1.2
	8212309	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.96	CHEMBL3023	Homo sapiens	Inhibition	%	0.96
	8212450	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.15	CHEMBL3023	Homo sapiens	Inhibition	%	0.15
	8212807	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.67	CHEMBL3023	Homo sapiens	Inhibition	%	0.67
	8212977	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.65	CHEMBL3023	Homo sapiens	Inhibition	%	0.65
	8213330	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.49	CHEMBL3023	Homo sapiens	Inhibition	%	0.49
	8213434	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-2.48	CHEMBL3023	Homo sapiens	Inhibition	%	-2.48
	8213658	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.29	CHEMBL3023	Homo sapiens	Inhibition	%	2.29
	8213771	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-3.19	CHEMBL3023	Homo sapiens	Inhibition	%	-3.19
	8214142	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.22	CHEMBL3023	Homo sapiens	Inhibition	%	-0.22
	8214279	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.33	CHEMBL3023	Homo sapiens	Inhibition	%	0.33
	8214503	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-2.47	CHEMBL3023	Homo sapiens	Inhibition	%	-2.47
	8214637	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.84	CHEMBL3023	Homo sapiens	Inhibition	%	0.84
	8214789	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.11	CHEMBL3023	Homo sapiens	Inhibition	%	-0.11
	8215013	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.79	CHEMBL3023	Homo sapiens	Inhibition	%	0.79
	8215264	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.3	CHEMBL3023	Homo sapiens	Inhibition	%	-0.3
	8215417	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-2.19	CHEMBL3023	Homo sapiens	Inhibition	%	-2.19
	8215805	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.37	CHEMBL3023	Homo sapiens	Inhibition	%	1.37
	8215924	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.95	CHEMBL3023	Homo sapiens	Inhibition	%	0.95
	8216267	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.23	CHEMBL3023	Homo sapiens	Inhibition	%	-0.23
	8216627	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8216765	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-0.37	CHEMBL3023	Homo sapiens	Inhibition	%	-0.37
	8217123	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-1.45	CHEMBL3023	Homo sapiens	Inhibition	%	-1.45
	8217297	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.77	CHEMBL3023	Homo sapiens	Inhibition	%	3.77
	8217652	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	0.46	CHEMBL3023	Homo sapiens	Inhibition	%	0.46
	8217977	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.32	CHEMBL3023	Homo sapiens	Inhibition	%	0.32
	8218092	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-0.49	CHEMBL3023	Homo sapiens	Inhibition	%	-0.49
	8218443	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.23	CHEMBL3023	Homo sapiens	Inhibition	%	0.23
	8218810	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.08	CHEMBL3023	Homo sapiens	Inhibition	%	0.08
	8218941	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.08	CHEMBL3023	Homo sapiens	Inhibition	%	0.08
	8219325	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.14	CHEMBL3023	Homo sapiens	Inhibition	%	-2.14
	8219575	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.84	CHEMBL3023	Homo sapiens	Inhibition	%	0.84
	8219736	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.04	CHEMBL3023	Homo sapiens	Inhibition	%	1.04
	8219960	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-0.88	CHEMBL3023	Homo sapiens	Inhibition	%	-0.88
	8220129	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.54	CHEMBL3023	Homo sapiens	Inhibition	%	-0.54
	8220258	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.89	CHEMBL3023	Homo sapiens	Inhibition	%	0.89
	8220482	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.35	CHEMBL3023	Homo sapiens	Inhibition	%	0.35
	8220596	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.48	CHEMBL3023	Homo sapiens	Inhibition	%	-0.48
	8220958	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-2.47	CHEMBL3023	Homo sapiens	Inhibition	%	-2.47
	8221094	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.67	CHEMBL3023	Homo sapiens	Inhibition	%	0.67
	8221318	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.53	CHEMBL3023	Homo sapiens	Inhibition	%	1.53
	8221451	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.64	CHEMBL3023	Homo sapiens	Inhibition	%	-0.64
	8221616	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.07	CHEMBL3023	Homo sapiens	Inhibition	%	-0.07
	8221840	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.62	CHEMBL3023	Homo sapiens	Inhibition	%	0.62
	8221971	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	-2.2	CHEMBL3023	Homo sapiens	Inhibition	%	-2.2
	8222293	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.25	CHEMBL3023	Homo sapiens	Inhibition	%	0.25
	8222427	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-0.4	CHEMBL3023	Homo sapiens	Inhibition	%	-0.4
	8222651	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-1.43	CHEMBL3023	Homo sapiens	Inhibition	%	-1.43
	8222769	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.39	CHEMBL3023	Homo sapiens	Inhibition	%	1.39
	8223137	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.05	CHEMBL3023	Homo sapiens	Inhibition	%	0.05
	8223266	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	17.64	CHEMBL3023	Homo sapiens	Inhibition	%	17.64
	8223490	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.1	CHEMBL3023	Homo sapiens	Inhibition	%	-0.1
	8223651	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.09	CHEMBL3023	Homo sapiens	Inhibition	%	0.09
	8223901	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-0.27	CHEMBL3023	Homo sapiens	Inhibition	%	-0.27
	8224287	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.74	CHEMBL3023	Homo sapiens	Inhibition	%	0.74
	8224457	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.77	CHEMBL3023	Homo sapiens	Inhibition	%	-0.77
	8224816	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.22	CHEMBL3023	Homo sapiens	Inhibition	%	0.22
	8224930	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.58	CHEMBL3023	Homo sapiens	Inhibition	%	0.58
	8225154	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.72	CHEMBL3023	Homo sapiens	Inhibition	%	0.72
	8225288	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.05	CHEMBL3023	Homo sapiens	Inhibition	%	0.05
	8225650	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.36	CHEMBL3023	Homo sapiens	Inhibition	%	-0.36
	8225785	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.33	CHEMBL3023	Homo sapiens	Inhibition	%	-0.33
	8226167	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.57	CHEMBL3023	Homo sapiens	Inhibition	%	0.57
	8226292	CHEMBL1962076	GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.13	CHEMBL3023	Homo sapiens	Inhibition	%	0.13
	8226516	CHEMBL1962077	GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-9.13	CHEMBL3023	Homo sapiens	Inhibition	%	-9.13
	10839500	CHEMBL2015531	Inhibition of SPHK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	6.0	CHEMBL3023	Homo sapiens	INH	%	6.0
	12047352	CHEMBL2157705	Inhibition of SPHK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.6	CHEMBL3023	Homo sapiens	INH	%	2.6
	12064819	CHEMBL2161993	Inhibition of SphK2 using sphingosine as substrate and [32gammaP]ATP after 15 to 20 mins by Cerenkov counting analysis	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	12064820	CHEMBL2161992	Inhibition of human recombinant SphK2 using NBD-sphingosine as substrate after 2 hrs by HPLC analysis	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	12064821	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158698	=	Ki	nM	29000.0	CHEMBL3023	Homo sapiens	Ki	uM	29.0
	12064822	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158697	=	Ki	nM	7000.0	CHEMBL3023	Homo sapiens	Ki	uM	7.0
	12064823	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158696	=	Ki	nM	8000.0	CHEMBL3023	Homo sapiens	Ki	uM	8.0
	12064824	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158695	=	Ki	nM	11000.0	CHEMBL3023	Homo sapiens	Ki	uM	11.0
	12064825	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158694	=	Ki	nM	43000.0	CHEMBL3023	Homo sapiens	Ki	uM	43.0
	12064826	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590	=	Ki	nM	21000.0	CHEMBL3023	Homo sapiens	Ki	uM	21.0
	12064827	CHEMBL2161991	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP by scintillation counting	B	CCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158693	=	Ki	nM	43000.0	CHEMBL3023	Homo sapiens	Ki	uM	43.0
	12064835	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCOc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158702	=	Activity	%	70.0	CHEMBL3023	Homo sapiens	Activity	%	70.0
	12064836	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCC#Cc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158701	=	Activity	%	28.0	CHEMBL3023	Homo sapiens	Activity	%	28.0
	12064837	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCC#Cc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158700	=	Activity	%	78.0	CHEMBL3023	Homo sapiens	Activity	%	78.0
	12064838	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCC#Cc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158699	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	12064839	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158698	=	Activity	%	70.0	CHEMBL3023	Homo sapiens	Activity	%	70.0
	12064840	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158697	=	Activity	%	38.0	CHEMBL3023	Homo sapiens	Activity	%	38.0
	12064841	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158696	=	Activity	%	26.0	CHEMBL3023	Homo sapiens	Activity	%	26.0
	12064842	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158695	=	Activity	%	50.0	CHEMBL3023	Homo sapiens	Activity	%	50.0
	12064843	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158694	=	Activity	%	26.0	CHEMBL3023	Homo sapiens	Activity	%	26.0
	12064844	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL1927590	=	Activity	%	64.0	CHEMBL3023	Homo sapiens	Activity	%	64.0
	12064845	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCc1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158693	=	Activity	%	98.0	CHEMBL3023	Homo sapiens	Activity	%	98.0
	12064846	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158692	=	Activity	%	58.0	CHEMBL3023	Homo sapiens	Activity	%	58.0
	12064847	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158691	=	Activity	%	50.0	CHEMBL3023	Homo sapiens	Activity	%	50.0
	12064848	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158690	=	Activity	%	41.0	CHEMBL3023	Homo sapiens	Activity	%	41.0
	12064849	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158689	=	Activity	%	40.0	CHEMBL3023	Homo sapiens	Activity	%	40.0
	12064850	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158688	=	Activity	%	75.0	CHEMBL3023	Homo sapiens	Activity	%	75.0
	12064851	CHEMBL2161989	Inhibition of recombinant SphK2 expressed in baculovirus infected Sf9 cells using D-erythro-sphingosine as substrate and [32gammaP]ATP assessed as residual activity at 10 uM by scintillation counting	B	CCCCCC(=O)c1ccc([C@H]2CC[C@H]([N+](C)(C)CCC)CC2)cc1.[I-]		CHEMBL2158687	=	Activity	%	71.0	CHEMBL3023	Homo sapiens	Activity	%	71.0
	12625621	CHEMBL2317615	Inhibition of SPHK2 (unknown origin) by ADP-GLO assay	B	CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL2316958	>	IC50	nM	1000.0	CHEMBL3023	Homo sapiens	IC50(app)	uM	1.0
	13374344	CHEMBL2405674	Inhibition of SPHK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1	Outside typical range	CHEMBL2402081	=	Inhibition	%	-14.0	CHEMBL3023	Homo sapiens	INH	%	-14.0
	13388312	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	Cl.N=C(N)[C@@H]1CCCN1C(=O)c1ccc(-c2nc(-c3cccc(CCC4CCCCC4)c3)co2)cc1		CHEMBL1774587	=	Ki	nM	4200.0	CHEMBL3023	Homo sapiens	Ki	uM	4.2
	13388313	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CCCCCCCCCCCCc1ccc(C(=O)NC2(C(=N)N)CC2)cc1.Cl		CHEMBL1092481	=	Ki	nM	500.0	CHEMBL3023	Homo sapiens	Ki	uM	0.5
	13388314	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CCCCCCCCc1ccc(NC(=O)[C@@H](N)CCO)cc1		CHEMBL583979	=	Ki	nM	31000.0	CHEMBL3023	Homo sapiens	Ki	uM	31.0
	13388315	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CCCCc1ccc(/C=C/[C@H](O)[C@@H](CO)NC)cc1		CHEMBL2409758	>	Ki	nM	100000.0	CHEMBL3023	Homo sapiens	Ki	uM	100.0
	13388316	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	13388325	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(C3CCCC3)cs2)cc1		CHEMBL2409846	>	IC50	nM	5000.0	CHEMBL3023	Homo sapiens	IC50	uM	5.0
	13388326	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CCCCc1csc(Nc2ccc(CCN3CC[C@H](O)C[C@@H]3CO)cc2)n1		CHEMBL2409892	>	IC50	nM	5000.0	CHEMBL3023	Homo sapiens	IC50	uM	5.0
	13388327	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3cccc(F)c3)cs2)cc1		CHEMBL2409882	>	IC50	nM	5000.0	CHEMBL3023	Homo sapiens	IC50	uM	5.0
	13388329	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CC(C)(C)c1csc(Nc2ccc(CCN3CC[C@H](O)C[C@@H]3CO)cc2)n1		CHEMBL2409893	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	13388330	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409866	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	13388331	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OCC1COCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409857	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	13388332	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OCCC1CCCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409855	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	13388333	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OCC1CCCCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409852	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	13388348	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409860	=	IC50	nM	7200.0	CHEMBL3023	Homo sapiens	IC50	uM	7.2
	13388350	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	COC[C@H]1CCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2407201	=	IC50	nM	5700.0	CHEMBL3023	Homo sapiens	IC50	uM	5.7
	13388351	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	Cc1ccccc1-c1csc(Nc2ccc(CCN3CCCC[C@@H]3CO)cc2)n1		CHEMBL2409873	=	IC50	nM	5500.0	CHEMBL3023	Homo sapiens	IC50	uM	5.5
	13388352	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	COc1ccccc1-c1csc(Nc2ccc(CCN3CCCC[C@@H]3CO)cc2)n1		CHEMBL2409874	=	IC50	nM	5400.0	CHEMBL3023	Homo sapiens	IC50	uM	5.4
	13388353	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(F)cc3)cs2)cc1		CHEMBL2409887	=	IC50	nM	4600.0	CHEMBL3023	Homo sapiens	IC50	uM	4.6
	13388354	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	C[C@]1(O)CCN(CCc2ccc(Nc3nc(-c4ccc5ccccc5c4)cs3)cc2)[C@@H](CO)C1		CHEMBL2409864	=	IC50	nM	3800.0	CHEMBL3023	Homo sapiens	IC50	uM	3.8
	13388355	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccccc3)cs2)cc1		CHEMBL2409871	=	IC50	nM	3700.0	CHEMBL3023	Homo sapiens	IC50	uM	3.7
	13388356	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC1CCN(CCc2ccc(Nc3nc(-c4ccc5ccccc5c4)cs3)cc2)CC1		CHEMBL2409854	=	IC50	nM	3300.0	CHEMBL3023	Homo sapiens	IC50	uM	3.3
	13388357	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC1CCCN(CCc2ccc(Nc3nc(-c4ccc5ccccc5c4)cs3)cc2)C1		CHEMBL2409853	=	IC50	nM	3300.0	CHEMBL3023	Homo sapiens	IC50	uM	3.3
	13388359	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	COc1cccc(-c2csc(Nc3ccc(CCN4CC[C@H](O)C[C@@H]4CO)cc3)n2)c1		CHEMBL2409885	=	IC50	nM	3000.0	CHEMBL3023	Homo sapiens	IC50	uM	3.0
	13388360	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	O=S1(=O)CCN(CCc2ccc(Nc3nc(-c4ccc(Cl)c(Cl)c4)cs3)cc2)C(CO)C1		CHEMBL2409858	=	IC50	nM	3000.0	CHEMBL3023	Homo sapiens	IC50	uM	3.0
	13388361	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OCC1CCCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409851	=	IC50	nM	2900.0	CHEMBL3023	Homo sapiens	IC50	uM	2.9
	13388362	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2407200	=	IC50	nM	2700.0	CHEMBL3023	Homo sapiens	IC50	uM	2.7
	13388363	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@@H]1CCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2407092	=	IC50	nM	2500.0	CHEMBL3023	Homo sapiens	IC50	uM	2.5
	13388364	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OCC1CCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2407199	=	IC50	nM	2500.0	CHEMBL3023	Homo sapiens	IC50	uM	2.5
	13388367	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@@H]1C[C@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409863	=	IC50	nM	2200.0	CHEMBL3023	Homo sapiens	IC50	uM	2.2
	13388368	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccccc3F)cs2)cc1		CHEMBL2409872	=	IC50	nM	2100.0	CHEMBL3023	Homo sapiens	IC50	uM	2.1
	13388373	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccccc3Cl)cs2)cc1		CHEMBL2407119	=	IC50	nM	1900.0	CHEMBL3023	Homo sapiens	IC50	uM	1.9
	13388375	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccccc3C(F)(F)F)cs2)cc1		CHEMBL2409875	=	IC50	nM	1700.0	CHEMBL3023	Homo sapiens	IC50	uM	1.7
	13388376	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409862	=	IC50	nM	1700.0	CHEMBL3023	Homo sapiens	IC50	uM	1.7
	13388377	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	CN1CCN(CCc2ccc(Nc3nc(-c4ccc5ccccc5c4)cs3)cc2)C(CO)C1		CHEMBL2409856	=	IC50	nM	1700.0	CHEMBL3023	Homo sapiens	IC50	uM	1.7
	13388378	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409865	=	IC50	nM	1600.0	CHEMBL3023	Homo sapiens	IC50	uM	1.6
	13388379	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409859	=	IC50	nM	1600.0	CHEMBL3023	Homo sapiens	IC50	uM	1.6
	13389257	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccccc3)cs2)cc1		CHEMBL2409879	=	IC50	nM	1300.0	CHEMBL3023	Homo sapiens	IC50	uM	1.3
	13389260	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3cccc(Cl)c3)cs2)cc1		CHEMBL2409876	=	IC50	nM	1200.0	CHEMBL3023	Homo sapiens	IC50	uM	1.2
	13389265	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	COc1ccc(-c2csc(Nc3ccc(CCN4CC[C@H](O)C[C@@H]4CO)cc3)n2)cc1		CHEMBL2409890	=	IC50	nM	940.0	CHEMBL3023	Homo sapiens	IC50	uM	0.94
	13389269	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1		CHEMBL2409861	=	IC50	nM	760.0	CHEMBL3023	Homo sapiens	IC50	uM	0.76
	13389271	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	Cc1cccc(-c2csc(Nc3ccc(CCN4CC[C@H](O)C[C@@H]4CO)cc3)n2)c1		CHEMBL2409884	=	IC50	nM	700.0	CHEMBL3023	Homo sapiens	IC50	uM	0.7
	13389274	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccccc3Cl)cs2)cc1		CHEMBL2409881	=	IC50	nM	430.0	CHEMBL3023	Homo sapiens	IC50	uM	0.43
	13389277	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(C3CCCCC3)cs2)cc1		CHEMBL2407198	=	IC50	nM	390.0	CHEMBL3023	Homo sapiens	IC50	uM	0.39
	13389279	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1CCCCN1CCc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL2409877	=	IC50	nM	370.0	CHEMBL3023	Homo sapiens	IC50	uM	0.37
	13389285	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CN1CCCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409868	=	IC50	nM	270.0	CHEMBL3023	Homo sapiens	IC50	uM	0.27
	13389288	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@H](O)CN1CCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409869	=	IC50	nM	250.0	CHEMBL3023	Homo sapiens	IC50	uM	0.25
	13389290	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccccc3F)cs2)cc1		CHEMBL2409880	=	IC50	nM	220.0	CHEMBL3023	Homo sapiens	IC50	uM	0.22
	13389292	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(C34CC5CC(CC(C5)C3)C4)cs2)cc1		CHEMBL2407197	=	IC50	nM	200.0	CHEMBL3023	Homo sapiens	IC50	uM	0.2
	13389293	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1		CHEMBL2409886	=	IC50	nM	170.0	CHEMBL3023	Homo sapiens	IC50	uM	0.17
	13389295	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3cccc(Cl)c3)cs2)cc1		CHEMBL2409883	=	IC50	nM	150.0	CHEMBL3023	Homo sapiens	IC50	uM	0.15
	13389306	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	Cc1ccc(-c2csc(Nc3ccc(CCN4CC[C@H](O)C[C@@H]4CO)cc3)n2)cc1		CHEMBL2409889	=	IC50	nM	110.0	CHEMBL3023	Homo sapiens	IC50	uM	0.11
	13389308	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1		CHEMBL2409891	=	IC50	nM	100.0	CHEMBL3023	Homo sapiens	IC50	uM	0.1
	13389310	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL2409888	=	IC50	nM	90.0	CHEMBL3023	Homo sapiens	IC50	uM	0.09
	13389311	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@H](O)CN1CCCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409870	=	IC50	nM	90.0	CHEMBL3023	Homo sapiens	IC50	uM	0.09
	13389312	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CN1CCc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1		CHEMBL2409867	=	IC50	nM	90.0	CHEMBL3023	Homo sapiens	IC50	uM	0.09
	13389319	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3cc(C(F)(F)F)ccc3F)cs2)cc1		CHEMBL2409850	=	IC50	nM	50.0	CHEMBL3023	Homo sapiens	IC50	uM	0.05
	13389322	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3cccc(C(F)(F)F)c3F)cs2)cc1		CHEMBL2409848	=	IC50	nM	40.0	CHEMBL3023	Homo sapiens	IC50	uM	0.04
	13389323	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(Cl)cc3Cl)cs2)cc1		CHEMBL2409847	=	IC50	nM	40.0	CHEMBL3023	Homo sapiens	IC50	uM	0.04
	13389330	CHEMBL2412223	Inhibition of purified human SphK2 assessed as inhibition of formation of [33P]-S1P after 50 mins by scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(C(F)(F)F)cc3F)cs2)cc1		CHEMBL2409849	=	IC50	nM	20.0	CHEMBL3023	Homo sapiens	IC50	uM	0.02
Dose-dependent effect	13838879	CHEMBL3088541	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCCCCCc1ccc(CCN2CCC[C@@H]2CO)cc1		CHEMBL3086796		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	13838886	CHEMBL3088541	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCCCCCc1ccc(CCN2CCC[C@@H]2CO)cc1		CHEMBL3086796	=	IC50	nM	5000.0	CHEMBL3023	Homo sapiens	IC50	uM	5.0
	13838887	CHEMBL3088541	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCN2CCC[C@@H]2CO)cc1		CHEMBL3086799	=	IC50	nM	5200.0	CHEMBL3023	Homo sapiens	IC50	uM	5.2
	13839210	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCN2CCC[C@H]2CO)cc1		CHEMBL3086800	=	Inhibition	%	45.7	CHEMBL3023	Homo sapiens	INH	%	45.7
	13839211	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCCCCCc1ccc(CCN2CCC[C@H]2CO)cc1		CHEMBL3086797	=	Inhibition	%	49.7	CHEMBL3023	Homo sapiens	INH	%	49.7
Active	13839215	CHEMBL3088787	Activity at sphingosine kinase 2 (unknown origin) at 50 uM after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCCCCCc1ccc(CCN2CCC[C@H]2CO)cc1		CHEMBL3086797		Activity			CHEMBL3023	Homo sapiens	Activity		
Active	13839216	CHEMBL3088787	Activity at sphingosine kinase 2 (unknown origin) at 50 uM after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCN2CCC[C@H]2CO)cc1		CHEMBL3086800		Activity			CHEMBL3023	Homo sapiens	Activity		
Not Active	13839217	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCc1cn(-c2ccc(CC[N+]3(C)CCCCC3)cc2)nn1.CS(=O)(=O)[O-]		CHEMBL3086783		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	13839218	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCc1cn(-c2ccc(CC[N+]3(C)CCCCC3)cc2)nn1.CS(=O)(=O)[O-]		CHEMBL3086784		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	13839219	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCc1cn(-c2ccc(CC[N+]3(C)CCCCC3)cc2)nn1.CS(=O)(=O)[O-]		CHEMBL3086785		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	13839220	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(C[n+]2ccc(N3CCC(C)CC3)cc2)cc1.[Br-]		CHEMBL3086786		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	13839221	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCc2ccc[n+](C)c2)cc1.[I-]		CHEMBL3086787		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	13839222	CHEMBL3088786	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate at 50 uM after 30 mins relative to control in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCN2CCC(=O)CC2)cc1		CHEMBL3086804		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	13839240	CHEMBL3088541	Inhibition of sphingosine kinase 2 (unknown origin) using sphingosine as substrate after 30 mins in presence of [gamma32P]-ATP	B	CCCCCCCCc1ccc(CCN2CCC[C@@H]2CO)cc1		CHEMBL3086799		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	13878038	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2cnc([C@@](C)(N)CO)[nH]2)cc1C(F)(F)F		CHEMBL3102894	=	Drug metabolism	%	14.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	14.0
	13878039	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2noc([C@@](C)(N)CO)n2)cc1C(F)(F)F		CHEMBL3102893	=	Drug metabolism	%	69.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	69.0
	13878040	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2cc([C@@](C)(N)CO)on2)cc1C(F)(F)F		CHEMBL3102892	=	Drug metabolism	%	84.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	84.0
	13878041	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2cc([C@@](C)(N)CO)[nH]n2)cc1C(F)(F)F		CHEMBL3102891	=	Drug metabolism	%	37.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	37.0
	13878042	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2nnc([C@@](C)(N)CO)o2)cc1C(F)(F)F		CHEMBL3102890	=	Drug metabolism	%	49.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	49.0
	13878043	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2nnc([C@@](C)(N)CO)s2)cc1C(F)(F)F		CHEMBL3102889	=	Drug metabolism	%	142.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	142.0
	13878044	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCOc1ccc(-c2cnc([C@@](C)(N)CO)s2)cc1C(F)(F)F		CHEMBL3102918	=	Drug metabolism	%	155.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	155.0
	13878045	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	C[C@](N)(CO)c1nnc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)s1		CHEMBL3102917	=	Drug metabolism	%	30.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	30.0
	13878046	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	C[C@](N)(CO)c1ncc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)s1		CHEMBL3102916	=	Drug metabolism	%	36.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	36.0
	13878047	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	C[C@](N)(CO)c1ncc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)o1		CHEMBL3102915	=	Drug metabolism	%	4.9	CHEMBL3023	Homo sapiens	Drug metabolism	%	4.9
	13878048	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	C[C@](N)(CO)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)cs1		CHEMBL3102914	=	Drug metabolism	%	2.1	CHEMBL3023	Homo sapiens	Drug metabolism	%	2.1
	13878049	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	Cc1oc([C@@](C)(N)CO)nc1-c1ccc(OCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1		CHEMBL3102913	=	Drug metabolism	%	6.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	6.0
	13878050	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	Cc1nc([C@@](C)(N)CO)[nH]c1-c1ccc(OCc2ccc(-c3ccccc3)cc2)c(C(F)(F)F)c1		CHEMBL3102912	=	Drug metabolism	%	4.1	CHEMBL3023	Homo sapiens	Drug metabolism	%	4.1
	13878051	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	NC(CO)(CO)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1		CHEMBL3102911	=	Drug metabolism	%	1.9	CHEMBL3023	Homo sapiens	Drug metabolism	%	1.9
	13878052	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	N[C@@H](CO)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1		CHEMBL3102910	=	Drug metabolism	%	2.8	CHEMBL3023	Homo sapiens	Drug metabolism	%	2.8
	13878053	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	C[C@](N)(CO)c1nc(-c2ccc(OCc3ccc(-c4ccccc4)cc3)c(C(F)(F)F)c2)c[nH]1		CHEMBL1093829	=	Drug metabolism	%	7.8	CHEMBL3023	Homo sapiens	Drug metabolism	%	7.8
	13878054	CHEMBL3106150	Prodrug conversion assessed as human SphK2-mediated formation of phosphorylated compound	A	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1		CHEMBL314854	=	Drug metabolism	%	100.0	CHEMBL3023	Homo sapiens	Drug metabolism	%	100.0
Active	13966333	CHEMBL3136696	Activity at purified SK2 (unknown origin) using ATP at 50 uM relative to control	B	CCCCCCCCCCCCC/C=C\[C@@H](O)[C@@H](N)CO		CHEMBL1453208		Activity			CHEMBL3023	Homo sapiens	Activity		
Active	13966337	CHEMBL3136688	Inhibition of SK2 (unknown origin) at 50 uM	B	CCCCCCCCCCCCc1ccc(C(=O)N2CCC[C@H]2C(=N)N)cc1.Cl		CHEMBL1774571		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	13966339	CHEMBL3136690	Inhibition of SK2 (unknown origin) at 1.5 uM	B	CCCCCCCCCCCCc1ccc(C(=O)N2CCC[C@H]2C(=N)N)cc1.Cl		CHEMBL1774571	=	Inhibition	%	73.4	CHEMBL3023	Homo sapiens	INH	%	73.4
	13966343	CHEMBL3136694	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 5 uM after 30 mins relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	33.3	CHEMBL3023	Homo sapiens	INH	%	33.3
Active	13966349	CHEMBL3136696	Activity at purified SK2 (unknown origin) using ATP at 50 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=S)Nc1cccc(C(F)(F)F)c1		CHEMBL3134155		Activity			CHEMBL3023	Homo sapiens	Activity		
Active	13966350	CHEMBL3136696	Activity at purified SK2 (unknown origin) using ATP at 50 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=S)Nc1cccc(F)c1		CHEMBL3134154		Activity			CHEMBL3023	Homo sapiens	Activity		
	13966351	CHEMBL3136697	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins	B	CCCCCCCCCCCCCCOC[C@@H](O)[C@H](C)N(C)C	Outside typical range	CHEMBL3134156	=	IC50	nM	300000.0	CHEMBL3023	Homo sapiens	IC50	uM	300.0
	13966352	CHEMBL3136697	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N	Outside typical range	CHEMBL1835439	=	IC50	nM	766000.0	CHEMBL3023	Homo sapiens	IC50	uM	766.0
	13966353	CHEMBL3136697	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate after 30 mins	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=S)Nc1cccc(C(F)(F)F)c1		CHEMBL3134155	=	IC50	nM	21800.0	CHEMBL3023	Homo sapiens	IC50	uM	21.8
	13966358	CHEMBL3136699	Inhibition of SK2 (unknown origin)	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
	13966359	CHEMBL3136699	Inhibition of SK2 (unknown origin)	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	13966362	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	72.2	CHEMBL3023	Homo sapiens	INH	%	72.2
	13966363	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=S)Nc1cccc(C(F)(F)F)c1		CHEMBL3134155	=	Inhibition	%	80.0	CHEMBL3023	Homo sapiens	INH	%	80.0
Active	13966364	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=S)Nc1cccc(F)c1		CHEMBL3134154		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	13966365	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=S)Nc1ccc(C(F)(F)F)cc1		CHEMBL3134152		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	13966366	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=S)Nc1ccc(F)cc1		CHEMBL3134151	=	Inhibition	%	79.2	CHEMBL3023	Homo sapiens	INH	%	79.2
	13966367	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL3134150	=	Inhibition	%	53.9	CHEMBL3023	Homo sapiens	INH	%	53.9
	13966368	CHEMBL3136701	Inhibition of purified SK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate at 50 uM after 30 mins relative to control	B	CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=S)Nc1ccc(F)cc1		CHEMBL3134149	=	Inhibition	%	64.5	CHEMBL3023	Homo sapiens	INH	%	64.5
	14726747	CHEMBL3294303	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Ki	nM	12000.0	CHEMBL3023	Homo sapiens	Ki	uM	12.0
	14726748	CHEMBL3294303	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCCCCCC/C=C/[C@H](O)[C@@H](CO)NC(=N)N.Cl		CHEMBL3287035	=	IC50	nM	300.0	CHEMBL3023	Homo sapiens	IC50	nM	300.0
	14726749	CHEMBL3294303	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	Ki	nM	27000.0	CHEMBL3023	Homo sapiens	Ki	uM	27.0
	14726750	CHEMBL3292342	Competitive inhibition of V5-His-tagged human SphK2 expressed in HEK293 cells assessed as S1P production using sphingosine and [gamma-32P]ATP as substrate by thin layer chromatography	B	CCCCCc1ccc(/C=C/[C@H](O)[C@@H](CO)NC)cc1		CHEMBL2376441	=	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	14726751	CHEMBL3292343	Inhibition of SphK2 (unknown origin) using sphingosine and [gamma-32P]ATP as substrate	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	4300.0	CHEMBL3023	Homo sapiens	Ki	uM	4.3
	14726752	CHEMBL3292344	Competitive inhibition of human recombinant SphK2 assessed as NBD-S1P formation using NBD-Sph as substrate by HPLC analysis	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	14726754	CHEMBL3292346	Competitive inhibition of human recombinant SphK2 using sphingosine and ATP as substrate by ADP-Quest kinase assay	B	O=C(NCCc1ccc(O)c(O)c1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL3287037	=	Ki	nM	4200.0	CHEMBL3023	Homo sapiens	Ki	uM	4.2
	15118248	CHEMBL3373187	Inhibition of human recombinant Sphk2 after 60 mins by ADP2 fluorescence intensity assay	B	Cc1csc(Nc2nc(-c3nccs3)cs2)n1		CHEMBL3334679	=	IC50	nM	6500.0	CHEMBL3023	Homo sapiens	IC50	uM	6.5
	15118250	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	14.7	CHEMBL3023	Homo sapiens	INH	%	14.7
	15118251	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(/C=C/C(=O)Nc2nccs2)cc(OC)c1OC		CHEMBL3334696	=	Inhibition	%	26.6	CHEMBL3023	Homo sapiens	INH	%	26.6
	15118252	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(/C=C/C(=O)Nc2nccs2)cc1OC		CHEMBL3334695	=	Inhibition	%	26.5	CHEMBL3023	Homo sapiens	INH	%	26.5
	15118253	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(/C=C/C(=O)Nc2nc(-c3ccc(Cl)cc3)cs2)cc(OC)c1OC		CHEMBL3334694	=	Inhibition	%	32.0	CHEMBL3023	Homo sapiens	INH	%	32.0
	15118254	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(/C=C/C(=O)Nc2nc(-c3ccc(Cl)cc3)cs2)cc1OC		CHEMBL3334693	=	Inhibition	%	31.7	CHEMBL3023	Homo sapiens	INH	%	31.7
Not Active	15118255	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CSc1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)c(C)s2)cc1		CHEMBL3334692		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15118256	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(Nc2nc(C3C4CC5CC(C4)CC3C5)c(C)s2)cc(OC)c1OC		CHEMBL3334691	=	Inhibition	%	21.5	CHEMBL3023	Homo sapiens	INH	%	21.5
	15118257	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccccc1Nc1nc(C2C3CC4CC(C3)CC2C4)c(C)s1		CHEMBL3334690	=	Inhibition	%	41.6	CHEMBL3023	Homo sapiens	INH	%	41.6
	15118258	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Cc1csc(Nc2nc(C3C4CC5CC(C4)CC3C5)c(C)s2)n1		CHEMBL3334689	=	Inhibition	%	20.9	CHEMBL3023	Homo sapiens	INH	%	20.9
	15118259	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	c1cc2c(cc1Nc1nc(C3C4CC5CC(C4)CC3C5)cs1)OCCO2		CHEMBL3334688	=	Inhibition	%	31.7	CHEMBL3023	Homo sapiens	INH	%	31.7
	15118260	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	c1cc2c(cc1Nc1nc(C3C4CC5CC(C4)CC3C5)cs1)OCO2		CHEMBL3334687	=	Inhibition	%	41.3	CHEMBL3023	Homo sapiens	INH	%	41.3
Not Active	15118261	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CN(C)c1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc1		CHEMBL3334686		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118262	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CC(C)c1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc1		CHEMBL3334685		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15118263	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CSc1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc1		CHEMBL3334684	=	Inhibition	%	18.6	CHEMBL3023	Homo sapiens	INH	%	18.6
	15118264	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccccc1Nc1nc(C2C3CC4CC(C3)CC2C4)cs1		CHEMBL3334683	=	Inhibition	%	19.0	CHEMBL3023	Homo sapiens	INH	%	19.0
	15118265	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc(OC)c1OC		CHEMBL3334682	=	Inhibition	%	20.8	CHEMBL3023	Homo sapiens	INH	%	20.8
Not Active	15118266	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc1OC		CHEMBL3353975		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118267	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(Nc2nc(C3C4CC5CC(C4)CC3C5)cs2)cc1		CHEMBL3334680		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15118268	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Cc1csc(Nc2nc(-c3nccs3)cs2)n1		CHEMBL3334679	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
Not Active	15118269	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Oc1ccc(Nc2nc(-c3nccs3)cs2)cc1		CHEMBL3334678		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15118270	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Cc1csc(Nc2nc(-c3ccc(Cl)cc3)c(C)s2)n1		CHEMBL3334677	=	Inhibition	%	19.2	CHEMBL3023	Homo sapiens	INH	%	19.2
Not Active	15118271	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CSc1ccc(Nc2nc(-c3ccc(Cl)cc3)c(C)s2)cc1		CHEMBL3334676		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118272	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(Nc2nc(-c3ccc(Cl)cc3)c(C)s2)cc(OC)c1OC		CHEMBL3334675		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118273	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(Nc2nc(-c3ccc(Cl)cc3)c(C)s2)cc1		CHEMBL2023851		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118274	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Cc1sc(Nc2ccc(O)cc2)nc1-c1ccc(Cl)cc1		CHEMBL3334674		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118275	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CN(C)c1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3334502		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118276	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CC(C)c1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3334673		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118277	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	FC(F)(F)c1cc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc(C(F)(F)F)c1		CHEMBL3318379		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118278	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	FC(F)(F)c1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3318377		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118279	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	FC(F)(F)Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3318378		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118280	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	CSc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3334672		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118281	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Clc1ccc(-c2csc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL3318381		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118282	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Clc1ccc(-c2csc(Nc3ccc4c(c3)OCO4)n2)cc1		CHEMBL2023847		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118283	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1cc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc(OC)c1OC		CHEMBL3334671		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118284	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	OCc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL3334670		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118285	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1080391		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118286	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccccc1Nc1nc(-c2ccc(Cl)cc2)cs1		CHEMBL3318372		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118287	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	COc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1OC		CHEMBL3318373		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118288	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Oc1ccccc1Nc1nc(-c2ccc(Cl)cc2)cs1		CHEMBL3318371		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Not Active	15118289	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Oc1cccc(Nc2nc(-c3ccc(Cl)cc3)cs2)c1		CHEMBL1087624		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15118290	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Oc1ccc(Nc2nc(-c3ccc(Br)cc3)cs2)cc1		CHEMBL3334669	=	Inhibition	%	13.6	CHEMBL3023	Homo sapiens	INH	%	13.6
	15118291	CHEMBL3373185	Inhibition of human recombinant Sphk2 at 10 uM after 60 mins by ADP2 fluorescence intensity assay	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Inhibition	%	15.5	CHEMBL3023	Homo sapiens	INH	%	15.5
	15213958	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(CNC(=N)N)n2)cc1.Cl		CHEMBL3416761	=	Activity	%	90.0	CHEMBL3023	Homo sapiens	Activity	%	90.0
	15213959	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(CN(C)C(=N)N)n2)cc1.Cl		CHEMBL3416762	=	Activity	%	90.0	CHEMBL3023	Homo sapiens	Activity	%	90.0
	15213960	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@H](C)NC(=N)N)n2)cc1.Cl		CHEMBL3416763	=	Activity	%	94.0	CHEMBL3023	Homo sapiens	Activity	%	94.0
	15213961	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H](NC(=N)N)C(C)C)n2)cc1.Cl		CHEMBL3416827	=	Activity	%	85.0	CHEMBL3023	Homo sapiens	Activity	%	85.0
	15213962	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@H](CO)NC(=N)N)n2)cc1.Cl		CHEMBL3416828	=	Activity	%	99.0	CHEMBL3023	Homo sapiens	Activity	%	99.0
	15213963	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(C3(NC(=N)N)CC3)n2)cc1.Cl		CHEMBL3416829	=	Activity	%	98.0	CHEMBL3023	Homo sapiens	Activity	%	98.0
	15213964	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416830	=	Activity	%	44.0	CHEMBL3023	Homo sapiens	Activity	%	44.0
	15213965	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416831	=	Activity	%	90.0	CHEMBL3023	Homo sapiens	Activity	%	90.0
	15213966	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3C=CCN3C(=N)N)n2)cc1.O=C(O)C(F)(F)F		CHEMBL3416832	=	Activity	%	96.0	CHEMBL3023	Homo sapiens	Activity	%	96.0
	15213967	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1.Cl		CHEMBL3416833	=	Activity	%	56.0	CHEMBL3023	Homo sapiens	Activity	%	56.0
	15213968	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416834	=	Activity	%	92.0	CHEMBL3023	Homo sapiens	Activity	%	92.0
	15213969	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3[C@@H](O)CCN3C(=N)N)n2)cc1.Cl		CHEMBL3416835	=	Activity	%	65.0	CHEMBL3023	Homo sapiens	Activity	%	65.0
	15213970	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3C[C@@H](O)CN3C(=N)N)n2)cc1.Cl		CHEMBL3416836	=	Activity	%	70.0	CHEMBL3023	Homo sapiens	Activity	%	70.0
	15213971	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3C[C@H](O)CN3C(=N)N)n2)cc1.Cl		CHEMBL3416837	=	Activity	%	90.0	CHEMBL3023	Homo sapiens	Activity	%	90.0
	15213972	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(C3CN(C(=N)N)C3)n2)cc1.Cl		CHEMBL3416838	=	Activity	%	96.0	CHEMBL3023	Homo sapiens	Activity	%	96.0
	15213973	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCN(C(=N)N)C3)n2)cc1.Cl		CHEMBL3416839	=	Activity	%	95.0	CHEMBL3023	Homo sapiens	Activity	%	95.0
	15213974	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2nc([C@@H]3CCCN3C(=N)N)no2)cc1.Cl		CHEMBL3416840	=	Activity	%	42.0	CHEMBL3023	Homo sapiens	Activity	%	42.0
	15213975	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2nnc([C@@H]3CCCN3C(=N)N)o2)cc1.O=C(O)C(F)(F)F		CHEMBL3416841	=	Activity	%	91.0	CHEMBL3023	Homo sapiens	Activity	%	91.0
	15213976	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCCCc1ccc(NC(=O)[C@@H]2CCCN2C(=N)N)cc1.O=C(O)C(F)(F)F		CHEMBL3416842	=	Activity	%	83.0	CHEMBL3023	Homo sapiens	Activity	%	83.0
	15213977	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCCCc1ccc(NC(=O)[C@H]2CCCN2C(=N)N)cc1.O=C(O)C(F)(F)F		CHEMBL3416843	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	15213978	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(CNC(=O)[C@@H]2CCCN2C(=N)N)cc1.O=C(O)C(F)(F)F		CHEMBL3416844	=	Activity	%	95.0	CHEMBL3023	Homo sapiens	Activity	%	95.0
	15213979	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(C(=O)NC[C@@H]2CCCN2C(=N)N)cc1.O=C(O)C(F)(F)F		CHEMBL3416845	=	Activity	%	75.0	CHEMBL3023	Homo sapiens	Activity	%	75.0
	15213980	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416846	=	Activity	%	80.0	CHEMBL3023	Homo sapiens	Activity	%	80.0
	15213981	CHEMBL3419996	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as enzyme activity measured as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP at 1 uM by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(CC[C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416847	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	15213995	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCc1ccc(/C=C/[C@H](O)[C@@H](CO)NC)cc1		CHEMBL2376441	>	Ki	nM	100000.0	CHEMBL3023	Homo sapiens	Ki	uM	100.0
	15213996	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	50000.0	CHEMBL3023	Homo sapiens	Ki	uM	50.0
	15213997	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCCCCCc1ccc(C(=O)N2CCC[C@H]2C(=N)N)cc1.Cl		CHEMBL1774571	=	Ki	nM	1500.0	CHEMBL3023	Homo sapiens	Ki	uM	1.5
	15213998	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1		CHEMBL2409891	=	IC50	nM	100.0	CHEMBL3023	Homo sapiens	IC50	uM	0.1
	15213999	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	15214000	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(CC[C@](N)(CO)COC)cc1		CHEMBL3416760	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	15214001	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	15214002	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416830	=	Ki	nM	1300.0	CHEMBL3023	Homo sapiens	Ki	uM	1.3
	15214003	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1.Cl		CHEMBL3416833	=	Ki	nM	1200.0	CHEMBL3023	Homo sapiens	Ki	uM	1.2
	15214004	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3[C@@H](O)CCN3C(=N)N)n2)cc1.Cl		CHEMBL3416835	>	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
	15214005	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@@H]3C[C@@H](O)CN3C(=N)N)n2)cc1.Cl		CHEMBL3416836	=	Ki	nM	5200.0	CHEMBL3023	Homo sapiens	Ki	uM	5.2
	15214006	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2nc([C@@H]3CCCN3C(=N)N)no2)cc1.Cl		CHEMBL3416840	=	Ki	nM	1100.0	CHEMBL3023	Homo sapiens	Ki	uM	1.1
	15214007	CHEMBL3419998	Inhibition of human recombinant SphK2 expressed in Sf9 cells assessed as radiolabeled products using 10 uM sphingosine and 10 uM gamma[32P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416846	>	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
Active	15214015	CHEMBL3420152	Inhibition of SphK2 in human U937 cells assessed as decrease in phosphorylated FTY720 substrate at 3 uM after 2 hrs incubation by LC-MS-MS analysis	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1.Cl		CHEMBL3416833		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	15748619	CHEMBL3630964	Inhibition of SphK2 (unknown origin)	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	15748620	CHEMBL3630964	Inhibition of SphK2 (unknown origin)	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
	15748621	CHEMBL3630964	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416830	=	Ki	nM	1300.0	CHEMBL3023	Homo sapiens	Ki	uM	1.3
Active	16381800	CHEMBL3737698	Inhibition of human recombinant SphK2 at 50 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCCCCCCCCCCCC(=O)Nc1nc2ccccc2[nH]1		CHEMBL3735039		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	16381801	CHEMBL3737697	Inhibition of human recombinant SphK2 at 500 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3735192		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	16381802	CHEMBL3737697	Inhibition of human recombinant SphK2 at 500 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCOc1ccc(N2C(=O)CC(Nc3ccc(CCO)cc3)C2=O)cc1		CHEMBL3736205		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	16381803	CHEMBL3737697	Inhibition of human recombinant SphK2 at 500 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCCCCCCCCCCCC(=O)Nc1nc2ccccc2[nH]1		CHEMBL3735039		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	16381813	CHEMBL3737698	Inhibition of human recombinant SphK2 at 50 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCOc1ccc(N2C(=O)CC(Nc3ccc(CCO)cc3)C2=O)cc1		CHEMBL3736205		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	16381814	CHEMBL3737698	Inhibition of human recombinant SphK2 at 50 uM preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3735192		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	16381819	CHEMBL3737700	Inhibition of human recombinant SphK2 preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	IC50	nM	16300.0	CHEMBL3023	Homo sapiens	IC50	uM	16.3
	16381820	CHEMBL3737700	Inhibition of human recombinant SphK2 preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCCCCCCCCCCCC(=O)Nc1nc2ccccc2[nH]1		CHEMBL3735039	=	IC50	nM	31300.0	CHEMBL3023	Homo sapiens	IC50	uM	31.3
	16381821	CHEMBL3737700	Inhibition of human recombinant SphK2 preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	CCCOc1ccc(N2C(=O)CC(Nc3ccc(CCO)cc3)C2=O)cc1		CHEMBL3736205	=	IC50	nM	62600.0	CHEMBL3023	Homo sapiens	IC50	uM	62.6
	16381822	CHEMBL3737700	Inhibition of human recombinant SphK2 preincubated for 5 mins followed by substrate addition measured for 60 mins by plate reader assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3735192	=	IC50	nM	17100.0	CHEMBL3023	Homo sapiens	IC50	uM	17.1
	16451613	CHEMBL3761194	Inhibition of SPHK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-9.8	CHEMBL3023	Homo sapiens	INH	%	-9.8
	16478051	CHEMBL3767372	Inhibition of human SK2 using D-erythro sphingosine as substrate and gamma[33P]ATP by Lineweaver-Burk plot analysis	B	Cc1ccc(S(=O)(=O)Nc2ccccc2/C=N/c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1		CHEMBL3764617	=	Ki	nM	6900.0	CHEMBL3023	Homo sapiens	Ki	uM	6.9
	16478052	CHEMBL3767369	Inhibition of recombinant SK2 (unknown origin) expressed in Sf9 cells assessed as [33P]S1P formation using D-erythro sphingosine as substrate and gamma[33P]ATP by liquid scintillation counting	B	CCCCCCCCc1ccc(-c2noc([C@H]3CCCN3C(=N)N)n2)cc1		CHEMBL3546834	=	Ki	nM	1300.0	CHEMBL3023	Homo sapiens	Ki	uM	1.3
	16478053	CHEMBL3767196	Inhibition of SK2 (unknown origin)	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	7900.0	CHEMBL3023	Homo sapiens	Ki	uM	7.9
	16478054	CHEMBL3767196	Inhibition of SK2 (unknown origin)	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
	16478055	CHEMBL3767196	Inhibition of SK2 (unknown origin)	B	N=C(N)[C@@H]1CCCN1C(=O)c1ccc(-c2nc(-c3cccc(CCC4CCCCC4)c3)co2)cc1		CHEMBL1789784	=	Ki	nM	4200.0	CHEMBL3023	Homo sapiens	Ki	uM	4.2
	16478056	CHEMBL3767196	Inhibition of SK2 (unknown origin)	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	>	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	IC50	uM	10.0
	16478057	CHEMBL3767196	Inhibition of SK2 (unknown origin)	B	OC[C@H]1C[C@H](O)CN1CCCc1ccc(Nc2nc(-c3cccc(C(F)(F)F)c3)cs2)cc1		CHEMBL3763321	=	IC50	nM	148.0	CHEMBL3023	Homo sapiens	IC50	nM	148.0
	16478059	CHEMBL3767370	Inhibition of recombinant SK2 (unknown origin) using sphingosine as substrate and gamma[32P]ATP by Lineweaver-Burk plot analysis	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	16478097	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Inhibition	%	90.0	CHEMBL3023	Homo sapiens	INH	%	90.0
	16478098	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	CCCCCCCc1nc(-c2ccc(CNC(=O)[C@H]3NCC[C@@H]3O)cc2)no1		CHEMBL1209322	=	Inhibition	%	112.0	CHEMBL3023	Homo sapiens	INH	%	112.0
	16478099	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	45.0	CHEMBL3023	Homo sapiens	INH	%	45.0
	16478100	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764169	=	Inhibition	%	44.0	CHEMBL3023	Homo sapiens	INH	%	44.0
	16478101	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(Cl)cc3)s2)cc1		CHEMBL3764893	=	Inhibition	%	70.0	CHEMBL3023	Homo sapiens	INH	%	70.0
	16478102	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(Cl)cc3)[nH]2)cc1		CHEMBL3764440	=	Inhibition	%	55.0	CHEMBL3023	Homo sapiens	INH	%	55.0
	16478103	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2noc(-c3ccc(Cl)cc3)n2)cc1		CHEMBL3763277	=	Inhibition	%	77.0	CHEMBL3023	Homo sapiens	INH	%	77.0
	16478104	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)no2)cc1		CHEMBL3763221	=	Inhibition	%	64.0	CHEMBL3023	Homo sapiens	INH	%	64.0
	16478105	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nsc(-c3ccc(Cl)cc3)n2)cc1		CHEMBL3764997	=	Inhibition	%	78.0	CHEMBL3023	Homo sapiens	INH	%	78.0
	16478106	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)ns2)cc1		CHEMBL3765046	=	Inhibition	%	68.0	CHEMBL3023	Homo sapiens	INH	%	68.0
	16478107	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)co2)cc1		CHEMBL3764301	=	Inhibition	%	56.0	CHEMBL3023	Homo sapiens	INH	%	56.0
	16478108	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.O=C(NCc1ccc(-c2noc(-c3ccc(Cl)cc3)n2)cc1)[C@H]1NCC[C@@H]1O		CHEMBL3763317	=	Inhibition	%	106.0	CHEMBL3023	Homo sapiens	INH	%	106.0
	16478109	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.O=C(NCc1ccc(-c2nc(-c3ccc(Cl)cc3)no2)cc1)[C@H]1NCC[C@@H]1O		CHEMBL3763654	=	Inhibition	%	118.0	CHEMBL3023	Homo sapiens	INH	%	118.0
	16478110	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764656	=	Inhibition	%	40.0	CHEMBL3023	Homo sapiens	INH	%	40.0
	16478111	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Sc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3763353	=	Inhibition	%	79.0	CHEMBL3023	Homo sapiens	INH	%	79.0
	16478112	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	O=C(Nc1ccc(O)cc1)c1nnc(-c2ccc(Cl)cc2)o1		CHEMBL3763791	=	Inhibition	%	139.0	CHEMBL3023	Homo sapiens	INH	%	139.0
	16478113	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.Oc1ccc(NCc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3763314	=	Inhibition	%	39.0	CHEMBL3023	Homo sapiens	INH	%	39.0
	16478114	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Nc1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3763362	=	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	16478115	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.NCc1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3765607	=	Inhibition	%	57.0	CHEMBL3023	Homo sapiens	INH	%	57.0
	16478116	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	O=C(O)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764861	=	Inhibition	%	40.0	CHEMBL3023	Homo sapiens	INH	%	40.0
	16478117	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	NC(=O)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3763194	=	Inhibition	%	104.0	CHEMBL3023	Homo sapiens	INH	%	104.0
	16478118	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.N=C(N)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3765738	=	Inhibition	%	89.0	CHEMBL3023	Homo sapiens	INH	%	89.0
	16478119	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	N/C(=N\O)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764632	=	Inhibition	%	102.0	CHEMBL3023	Homo sapiens	INH	%	102.0
	16478120	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.N=C(N)[C@@H]1CCCN1C(=O)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764885	=	Inhibition	%	135.0	CHEMBL3023	Homo sapiens	INH	%	135.0
	16478121	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Clc1ccc(-c2nnc(-c3ccc(-c4nn[nH]n4)cc3)o2)cc1		CHEMBL3764698	=	Inhibition	%	14.0	CHEMBL3023	Homo sapiens	INH	%	14.0
	16478122	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	NC(=O)c1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3765075	=	Inhibition	%	43.0	CHEMBL3023	Homo sapiens	INH	%	43.0
	16478123	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.N=C(N)c1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3765725	=	Inhibition	%	14.0	CHEMBL3023	Homo sapiens	INH	%	14.0
	16478124	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	N/C(=N\O)c1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3765215	=	Inhibition	%	121.0	CHEMBL3023	Homo sapiens	INH	%	121.0
	16478125	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Clc1ccc(-c2nnc(Nc3ccc(-c4nn[nH]n4)cc3)o2)cc1		CHEMBL3764220	=	Inhibition	%	70.0	CHEMBL3023	Homo sapiens	INH	%	70.0
	16478126	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	O/N=C/c1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL3764756	=	Inhibition	%	71.0	CHEMBL3023	Homo sapiens	INH	%	71.0
	16478127	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccccc3)o2)cc1		CHEMBL3763228	=	Inhibition	%	23.0	CHEMBL3023	Homo sapiens	INH	%	23.0
	16478128	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(C(F)(F)F)cc3)o2)cc1		CHEMBL3763355	=	Inhibition	%	17.0	CHEMBL3023	Homo sapiens	INH	%	17.0
	16478129	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(I)cc3)o2)cc1		CHEMBL3764032	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	16478130	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(CCC4CCCCC4)cc3)o2)cc1		CHEMBL3764565	=	Inhibition	%	144.0	CHEMBL3023	Homo sapiens	INH	%	144.0
	16478131	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cl.O=C(NCc1ccncc1)c1nnc(-c2ccc(Cl)cc2)o1		CHEMBL3763566	=	Inhibition	%	73.0	CHEMBL3023	Homo sapiens	INH	%	73.0
	16478132	CHEMBL3767198	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using sphingosine as substrate at 10 uM by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Clc1ccc(-c2nnc(NCc3ccncc3)o2)cc1		CHEMBL3763496	=	Inhibition	%	39.0	CHEMBL3023	Homo sapiens	INH	%	39.0
	16479074	CHEMBL3767365	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	IC50	nM	17000.0	CHEMBL3023	Homo sapiens	IC50	uM	17.0
	16479075	CHEMBL3767365	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Oc1ccc(Nc2nnc(-c3ccc(I)cc3)o2)cc1		CHEMBL3764032	=	IC50	nM	1900.0	CHEMBL3023	Homo sapiens	IC50	uM	1.9
	16479076	CHEMBL3767365	Inhibition of recombinant human SK2 assessed as production of [32P] S1P using 10 uM sphingosine as substrate by TLC method in presence of 100 uM [gamma32P]-ATP relative to control	B	Clc1ccc(-c2nnc(NCc3ccncc3)o2)cc1		CHEMBL3763496	=	IC50	nM	5500.0	CHEMBL3023	Homo sapiens	IC50	uM	5.5
	16599941	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCc1ccc(-c2noc(C3(C(=N)N)CC3)n2)cc1.Cl		CHEMBL3809598	=	Ki	nM	6000.0	CHEMBL3023	Homo sapiens	Ki	uM	6.0
	16599942	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCc1ccc(-c2noc(C3(C(=N)N)CC3)n2)cc1.Cl		CHEMBL3809326	=	Ki	nM	43000.0	CHEMBL3023	Homo sapiens	Ki	uM	43.0
	16599943	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1ccc(-c2noc(C3(C(=N)N)CC3)n2)cc1.Cl		CHEMBL3809675	=	Ki	nM	6000.0	CHEMBL3023	Homo sapiens	Ki	uM	6.0
	16599944	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCCc1ccc(-c2noc(C3(C(=N)N)CC3)n2)cc1.Cl		CHEMBL3808979	=	Ki	nM	11000.0	CHEMBL3023	Homo sapiens	Ki	uM	11.0
	16599945	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1cccc(C(=O)NC2(C(=N)N)CC2)c1.Cl		CHEMBL3809710	=	Ki	nM	10900.0	CHEMBL3023	Homo sapiens	Ki	uM	10.9
	16599946	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCc1cccc(-c2noc(C3(C(=N)N)CC3)n2)c1.Cl		CHEMBL3809162	=	Ki	nM	10300.0	CHEMBL3023	Homo sapiens	Ki	uM	10.3
	16599947	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCc1cccc(-c2noc(C3(C(=N)N)CC3)n2)c1.Cl		CHEMBL3809554	=	Ki	nM	9900.0	CHEMBL3023	Homo sapiens	Ki	uM	9.9
	16599948	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1cccc(-c2noc(C3(C(=N)N)CC3)n2)c1.Cl		CHEMBL3809146	=	Ki	nM	14100.0	CHEMBL3023	Homo sapiens	Ki	uM	14.1
	16599949	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCCc1cccc(-c2noc(C3(C(=N)N)CC3)n2)c1.Cl		CHEMBL3809544	=	Ki	nM	11700.0	CHEMBL3023	Homo sapiens	Ki	uM	11.7
	16599950	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1ccc(-c2nc(C3(C(=N)N)CC3)no2)cc1.Cl		CHEMBL3808554	=	Ki	nM	3400.0	CHEMBL3023	Homo sapiens	Ki	uM	3.4
	16599951	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1cccc(-c2nc(C3(C(=N)N)CC3)no2)c1.Cl		CHEMBL3809605	=	Ki	nM	10200.0	CHEMBL3023	Homo sapiens	Ki	uM	10.2
	16599952	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1ccc(-c2nnc(C3(C(=N)N)CC3)o2)cc1.Cl		CHEMBL3809791	=	Ki	nM	1200.0	CHEMBL3023	Homo sapiens	Ki	uM	1.2
	16599953	CHEMBL3811132	Inhibition of human SphK2 expressed in baculovirus infected in Sf9 cells using D-erythro-sphingosine as substrate and [gamma-32P]ATP by scintillation counting method	B	CCCCCCCCCCCCc1cccc(-c2nnc(C3(C(=N)N)CC3)o2)c1.Cl		CHEMBL3810270	=	Ki	nM	8100.0	CHEMBL3023	Homo sapiens	Ki	uM	8.1
	16611637	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416830	=	Activity	%	61.0	CHEMBL3023	Homo sapiens	Activity	%	61.0
	16611638	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(O)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814943	=	Activity	%	106.0	CHEMBL3023	Homo sapiens	Activity	%	106.0
	16611639	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814580	=	Activity	%	69.0	CHEMBL3023	Homo sapiens	Activity	%	69.0
	16611640	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3813833	=	Activity	%	51.0	CHEMBL3023	Homo sapiens	Activity	%	51.0
	16611641	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3813772	=	Activity	%	64.0	CHEMBL3023	Homo sapiens	Activity	%	64.0
	16611642	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3815040	=	Activity	%	83.0	CHEMBL3023	Homo sapiens	Activity	%	83.0
	16611643	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CC(C)COc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3815165	=	Activity	%	74.0	CHEMBL3023	Homo sapiens	Activity	%	74.0
	16611644	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCC4CCCC4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814835	=	Activity	%	57.0	CHEMBL3023	Homo sapiens	Activity	%	57.0
	16611645	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	COCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.O=C(O)C(F)(F)F		CHEMBL3815122	=	Activity	%	118.0	CHEMBL3023	Homo sapiens	Activity	%	118.0
	16611646	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	COCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.O=C(O)C(F)(F)F		CHEMBL3814973	=	Activity	%	109.0	CHEMBL3023	Homo sapiens	Activity	%	109.0
	16611647	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccccc4)ccc3c2)no1		CHEMBL3814966	=	Activity	%	97.0	CHEMBL3023	Homo sapiens	Activity	%	97.0
	16611648	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cc1ccc(COc2ccc3cc(-c4noc([C@@H]5CCCN5C(=N)N)n4)ccc3c2)cc1.Cl		CHEMBL3814715	=	Activity	%	94.0	CHEMBL3023	Homo sapiens	Activity	%	94.0
	16611649	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cc1ccc(S(=O)(=O)Oc2ccc3cc(-c4noc([C@@H]5CCCN5C(=N)N)n4)ccc3c2)cc1.Cl		CHEMBL3814141	=	Activity	%	89.0	CHEMBL3023	Homo sapiens	Activity	%	89.0
	16611650	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(C(F)(F)F)cc4)ccc3c2)no1		CHEMBL3814849	=	Activity	%	42.0	CHEMBL3023	Homo sapiens	Activity	%	42.0
	16611651	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4cccc(C(F)(F)F)c4)ccc3c2)no1		CHEMBL3814786	=	Activity	%	81.0	CHEMBL3023	Homo sapiens	Activity	%	81.0
	16611652	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(Br)cc4)ccc3c2)no1		CHEMBL3814331	=	Activity	%	35.0	CHEMBL3023	Homo sapiens	Activity	%	35.0
	16611653	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4cccc(Br)c4)ccc3c2)no1		CHEMBL3814499	=	Activity	%	49.0	CHEMBL3023	Homo sapiens	Activity	%	49.0
	16611654	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(Cl)cc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3813786	=	Activity	%	56.0	CHEMBL3023	Homo sapiens	Activity	%	56.0
	16611655	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4cccc(Cl)c4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814180	=	Activity	%	46.0	CHEMBL3023	Homo sapiens	Activity	%	46.0
	16611656	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N#Cc1ccc(COc2ccc3cc(-c4noc([C@@H]5CCCN5C(=N)N)n4)ccc3c2)cc1.O=C(O)C(F)(F)F		CHEMBL3813910	=	Activity	%	43.0	CHEMBL3023	Homo sapiens	Activity	%	43.0
	16611657	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(-c5ccccc5)cc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814392	=	Activity	%	51.0	CHEMBL3023	Homo sapiens	Activity	%	51.0
	16611658	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CC1(C)CCC(C)(C)c2cc(COc3ccc4cc(-c5noc([C@@H]6CCCN6C(=N)N)n5)ccc4c3)ccc21.O=C(O)C(F)(F)F		CHEMBL3814161	=	Activity	%	104.0	CHEMBL3023	Homo sapiens	Activity	%	104.0
	16611659	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCCc4ccc(C(F)(F)F)cc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814085	=	Activity	%	30.0	CHEMBL3023	Homo sapiens	Activity	%	30.0
	16611660	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCCc4cccc(C(F)(F)F)c4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814096	=	Activity	%	34.0	CHEMBL3023	Homo sapiens	Activity	%	34.0
	16611661	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCCc4ccccc4C(F)(F)F)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814586	=	Activity	%	47.0	CHEMBL3023	Homo sapiens	Activity	%	47.0
	16611662	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCC(=O)c4ccccc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3813780	=	Activity	%	103.0	CHEMBL3023	Homo sapiens	Activity	%	103.0
	16611663	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCC(=O)c4ccc(C(F)(F)F)cc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814861	=	Activity	%	65.0	CHEMBL3023	Homo sapiens	Activity	%	65.0
	16611664	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCC(=O)c4ccc(-c5ccccc5)cc4)ccc3c2)no1.O=C(O)C(F)(F)F		CHEMBL3814788	=	Activity	%	77.0	CHEMBL3023	Homo sapiens	Activity	%	77.0
	16611665	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCOc1ccc2cc(-c3noc([C@@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814505	=	Activity	%	46.0	CHEMBL3023	Homo sapiens	Activity	%	46.0
	16611666	CHEMBL3816944	Inhibition of human recombinant SphK2 remaining enzyme activity at 1 uM using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CC(C)COc1ccc2cc(-c3noc([C@@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814234	=	Activity	%	53.0	CHEMBL3023	Homo sapiens	Activity	%	53.0
	16611673	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416830	=	Ki	nM	1400.0	CHEMBL3023	Homo sapiens	Ki	uM	1.4
	16611674	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3813833	=	Ki	nM	980.0	CHEMBL3023	Homo sapiens	Ki	uM	0.98
	16611675	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3813772	=	Ki	nM	3800.0	CHEMBL3023	Homo sapiens	Ki	uM	3.8
	16611676	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(C(F)(F)F)cc4)ccc3c2)no1	Potential transcription error	CHEMBL3814849	=	Ki	nM	1020.0	CHEMBL3023	Homo sapiens	Ki	uM	1.02
	16611677	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CCCCCOc1ccc2cc(-c3noc([C@@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814505	=	Ki	nM	900.0	CHEMBL3023	Homo sapiens	Ki	uM	0.9
	16611678	CHEMBL3816946	Inhibition of human recombinant SphK2 using sphingosine as substrate incubated for 20 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	CC(C)COc1ccc2cc(-c3noc([C@@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814234	=	Ki	nM	980.0	CHEMBL3023	Homo sapiens	Ki	uM	0.98
	16611685	CHEMBL3816948	Inhibition of human recombinant SphK2 after 2 hrs by HPLC assay	B	O=C(CC12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2)NCc1ccncc1		CHEMBL3814083	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	16611688	CHEMBL3816949	Inhibition of SphK2 (unknown origin)	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	16611689	CHEMBL3816949	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	16611693	CHEMBL3817021	Inhibition of human SphK2 using sphingosine as substrate incubated for 50 mins by scintillation counting analysis in presence of [gamma-33P]ATP	B	OC[C@H]1C[C@@H](O)CCN1CCc1ccc(Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1		CHEMBL2409891	=	IC50	nM	20.0	CHEMBL3023	Homo sapiens	IC50	uM	0.02
	16615397	CHEMBL3816959	Inhibition of SPHK2 (unknown origin)	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	50000.0	CHEMBL3023	Homo sapiens	Ki	uM	50.0
	16615399	CHEMBL3816957	Inhibition of His-tagged full length human recombinant SPHK2 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay	B	O=C(NCc1ccc(O)c(O)c1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL3814457	=	Ki	nM	4200.0	CHEMBL3023	Homo sapiens	Ki	uM	4.2
	16615400	CHEMBL3816957	Inhibition of His-tagged full length human recombinant SPHK2 expressed in baculovirus infected fall armyworm Sf9 cell expression system using sphingosine as substrate by ADP-quest assay	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Ki	nM	14000.0	CHEMBL3023	Homo sapiens	Ki	uM	14.0
	16615414	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3735192	=	IC50	nM	26330.0	CHEMBL3023	Homo sapiens	IC50	uM	26.33
	16615415	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	Cc1ccccc1COc1cccc(/C=N/NC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL3814691	=	IC50	nM	81170.0	CHEMBL3023	Homo sapiens	IC50	uM	81.17
	16615416	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	Cc1cccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)c1		CHEMBL3814845	=	IC50	nM	78690.0	CHEMBL3023	Homo sapiens	IC50	uM	78.69
	16615417	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	Cc1ccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)cc1		CHEMBL3814930	=	IC50	nM	65380.0	CHEMBL3023	Homo sapiens	IC50	uM	65.38
	16615418	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2C(F)(F)F)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814886	=	IC50	nM	16320.0	CHEMBL3023	Homo sapiens	IC50	uM	16.32
	16615419	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2cccc(C(F)(F)F)c2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3813857	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615420	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccc(C(F)(F)F)cc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3813765	=	IC50	nM	22150.0	CHEMBL3023	Homo sapiens	IC50	uM	22.15
	16615421	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2F)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814912	=	IC50	nM	98900.0	CHEMBL3023	Homo sapiens	IC50	uM	98.9
	16615422	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2cccc(F)c2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3813986	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615423	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccc(F)cc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814271	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615424	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2Cl)c1)c1cc(O)c(O)c(O)c1		CHEMBL3815035	=	IC50	nM	58790.0	CHEMBL3023	Homo sapiens	IC50	uM	58.79
	16615425	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2cccc(Cl)c2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814059	=	IC50	nM	67370.0	CHEMBL3023	Homo sapiens	IC50	uM	67.37
	16615426	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccc(Cl)cc2)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814091	=	IC50	nM	61200.0	CHEMBL3023	Homo sapiens	IC50	uM	61.2
	16615427	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	CC(C)(C)c1ccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)cc1		CHEMBL3814622	=	IC50	nM	62170.0	CHEMBL3023	Homo sapiens	IC50	uM	62.17
	16615428	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1ccccc1COc1cccc(/C=N/NC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL3814989	=	IC50	nM	68550.0	CHEMBL3023	Homo sapiens	IC50	uM	68.55
	16615429	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1cccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)c1		CHEMBL3815047	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615430	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1ccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)cc1		CHEMBL3814810	=	IC50	nM	35110.0	CHEMBL3023	Homo sapiens	IC50	uM	35.11
	16615431	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2cccc3ccccc23)c1)c1cc(O)c(O)c(O)c1		CHEMBL3814839	=	IC50	nM	40580.0	CHEMBL3023	Homo sapiens	IC50	uM	40.58
	16615432	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1ccccc1COc1cccc(/C=N/NC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL3814046	=	IC50	nM	19530.0	CHEMBL3023	Homo sapiens	IC50	uM	19.53
	16615433	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)c1		CHEMBL3814439	=	IC50	nM	8700.0	CHEMBL3023	Homo sapiens	IC50	uM	8.7
	16615434	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1ccc(COc2cccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)c2)cc1		CHEMBL3814312	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615435	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2)cc1)c1cc(O)c(O)c(O)c1		CHEMBL3814218	=	IC50	nM	28510.0	CHEMBL3023	Homo sapiens	IC50	uM	28.51
	16615436	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2C(F)(F)F)cc1)c1cc(O)c(O)c(O)c1		CHEMBL3814488	=	IC50	nM	15080.0	CHEMBL3023	Homo sapiens	IC50	uM	15.08
	16615437	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2cccc(C(F)(F)F)c2)cc1)c1cc(O)c(O)c(O)c1		CHEMBL3813988	=	IC50	nM	23830.0	CHEMBL3023	Homo sapiens	IC50	uM	23.83
	16615438	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccc(C(F)(F)F)cc2)cc1)c1cc(O)c(O)c(O)c1		CHEMBL3813951	=	IC50	nM	15640.0	CHEMBL3023	Homo sapiens	IC50	uM	15.64
	16615439	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1ccccc1COc1ccc(/C=N/NC(=O)c2cc(O)c(O)c(O)c2)cc1		CHEMBL3814779	=	IC50	nM	44540.0	CHEMBL3023	Homo sapiens	IC50	uM	44.54
	16615440	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1cccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)c1		CHEMBL3814285	=	IC50	nM	22590.0	CHEMBL3023	Homo sapiens	IC50	uM	22.59
	16615441	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	N#Cc1ccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1		CHEMBL3814709	=	IC50	nM	17790.0	CHEMBL3023	Homo sapiens	IC50	uM	17.79
	16615442	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	Cc1ccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1		CHEMBL3814984	=	IC50	nM	44500.0	CHEMBL3023	Homo sapiens	IC50	uM	44.5
	16615443	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	CC(C)(C)c1ccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1		CHEMBL3813759	=	IC50	nM	43280.0	CHEMBL3023	Homo sapiens	IC50	uM	43.28
	16615444	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccc3ccccc3c2)cc1)c1cc(O)c(O)c(O)c1		CHEMBL3815133	=	IC50	nM	30230.0	CHEMBL3023	Homo sapiens	IC50	uM	30.23
	16615445	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1ccccc1COc1ccc(/C=N/NC(=O)c2cc(O)c(O)c(O)c2)cc1		CHEMBL3815127	=	IC50	nM	26620.0	CHEMBL3023	Homo sapiens	IC50	uM	26.62
	16615446	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)c1		CHEMBL3814880	=	IC50	nM	2170.0	CHEMBL3023	Homo sapiens	IC50	uM	2.17
	16615447	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1ccc(COc2ccc(/C=N/NC(=O)c3cc(O)c(O)c(O)c3)cc2)cc1		CHEMBL3814524	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615448	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2)c1)c1ccc2[nH]cnc2c1		CHEMBL3814344	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615449	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2cccc(/C=N/NC(=O)c3cc(O)cc(O)c3)c2)c1		CHEMBL3813737	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615450	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2cccc(/C=N/NC(=O)c3ccc(O)c(O)c3)c2)c1		CHEMBL3814464	=	IC50	nM	4600.0	CHEMBL3023	Homo sapiens	IC50	uM	4.6
	16615451	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2cccc(/C=N/NC(=O)c3cccc(O)c3)c2)c1		CHEMBL3813800	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615452	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2cccc(/C=N/NC(=O)c3ccc(O)cc3)c2)c1		CHEMBL3814952	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615453	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2ccc(/C=N/NC(=O)c3cc(O)cc(O)c3)cc2)c1		CHEMBL3814178	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615454	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2ccc(/C=N/NC(=O)c3ccc(O)c(O)c3)cc2)c1		CHEMBL3813893	=	IC50	nM	10150.0	CHEMBL3023	Homo sapiens	IC50	uM	10.15
	16615455	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2ccc(/C=N/NC(=O)c3cccc(O)c3)cc2)c1		CHEMBL3813749	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615456	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	COc1cccc(COc2ccc(/C=N/NC(=O)c3ccc(O)cc3)cc2)c1		CHEMBL3814396	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615457	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2C(F)(F)F)c1)c1cc(O)cc(O)c1		CHEMBL3814450	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615458	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2C(F)(F)F)c1)c1ccc(O)c(O)c1		CHEMBL3814728	=	IC50	nM	13840.0	CHEMBL3023	Homo sapiens	IC50	uM	13.84
	16615459	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2C(F)(F)F)c1)c1cccc(O)c1		CHEMBL3814603	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615460	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1cccc(OCc2ccccc2C(F)(F)F)c1)c1ccc(O)cc1		CHEMBL3813816	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615461	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2C(F)(F)F)cc1)c1cc(O)cc(O)c1		CHEMBL3814087	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615462	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2C(F)(F)F)cc1)c1ccc(O)c(O)c1		CHEMBL3814127	=	IC50	nM	11400.0	CHEMBL3023	Homo sapiens	IC50	uM	11.4
	16615463	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2C(F)(F)F)cc1)c1cccc(O)c1		CHEMBL3814697	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615464	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	O=C(N/N=C/c1ccc(OCc2ccccc2C(F)(F)F)cc1)c1ccc(O)cc1		CHEMBL3815019	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	16615465	CHEMBL3816961	Inhibition of GST-tagged full length human recombinant SPHK2 expressed in baculovirus using sphingosine as substrate preincubated for 10 mins measured after 1 hr by ADP-quest assay	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	IC50	nM	26290.0	CHEMBL3023	Homo sapiens	IC50	uM	26.29
	16615486	CHEMBL3816959	Inhibition of SPHK2 (unknown origin)	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	16618657	CHEMBL3816616	Inhibition of full length recombinant human GST-tagged SPHK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	18040898	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1nc2ccc(-c3ccc(CN4CCC[C@@H]4CO)cc3)cc2n1C[C@H]1CCCO1		CHEMBL4082814	=	IC50	nM	46000.0	CHEMBL3023	Homo sapiens	IC50	uM	46.0
	18040899	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1nc2ccc(-c3ccc(CN4CCC[C@@H]4CO)cc3)cc2n1C[C@@H]1CCCO1		CHEMBL4067356	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	18040900	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1nc2ccc(-c3ccc(CN4CCC[C@H]4CO)cc3)cc2n1C[C@H]1CCCO1		CHEMBL4088607	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	18040901	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1nc2ccc(-c3ccc(CN4CCC[C@H]4CO)cc3)cc2n1C[C@@H]1CCCO1		CHEMBL4064624	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	18040902	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	IC50	nM	356.0	CHEMBL3023	Homo sapiens	IC50	nM	356.0
	18040903	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@H]3CO)cc2)c1		CHEMBL3348835	=	IC50	nM	42600.0	CHEMBL3023	Homo sapiens	IC50	nM	42600.0
	18040904	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CC[C@H](O)C3)cc2)c1		CHEMBL4077280	=	IC50	nM	443.0	CHEMBL3023	Homo sapiens	IC50	nM	443.0
Not Determined	18040905	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CC[C@@H](O)C3)cc2)c1		CHEMBL4077075		IC50			CHEMBL3023	Homo sapiens	IC50		
	18040906	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3C[C@@H](O)[C@H](O)C3)cc2)c1		CHEMBL4061789	=	IC50	nM	465.0	CHEMBL3023	Homo sapiens	IC50	nM	465.0
	18040907	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3C[C@H](O)[C@H](O)C3)cc2)c1		CHEMBL4063424	=	IC50	nM	7230.0	CHEMBL3023	Homo sapiens	IC50	nM	7230.0
	18040908	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CNCCO)cc2)c1		CHEMBL4103414	=	IC50	nM	35100.0	CHEMBL3023	Homo sapiens	IC50	nM	35100.0
	18040909	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	O=S(=O)(Cc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1)c1ccccc1		CHEMBL4090361	=	IC50	nM	164.0	CHEMBL3023	Homo sapiens	IC50	nM	164.0
	18040910	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	O=S(=O)(Cc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1)C1CC1		CHEMBL4069327	=	IC50	nM	164.0	CHEMBL3023	Homo sapiens	IC50	nM	164.0
Not Determined	18040911	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	CS(=O)(=O)Cc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL4093845		IC50			CHEMBL3023	Homo sapiens	IC50		
	18040912	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(C3CCCCC3)c2)cc1		CHEMBL4066270	<	IC50	nM	1.7	CHEMBL3023	Homo sapiens	IC50	nM	1.7
	18040913	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	CC(C)c1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL4086094	<	IC50	nM	1.7	CHEMBL3023	Homo sapiens	IC50	nM	1.7
	18040914	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1nc(-c2cccc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c2)no1		CHEMBL4104017	=	IC50	nM	2.4	CHEMBL3023	Homo sapiens	IC50	nM	2.4
	18040915	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	O=C(Nc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1)c1ccccc1		CHEMBL4063506	=	IC50	nM	145.0	CHEMBL3023	Homo sapiens	IC50	nM	145.0
	18040916	CHEMBL4009723	Inhibition of SPHK2 (unknown origin) by FITC-based caliper assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc3[nH]c(N)nc3c2)c1		CHEMBL4101573	=	IC50	nM	39600.0	CHEMBL3023	Homo sapiens	IC50	uM	39.6
	18069861	CHEMBL4015084	Inhibition of human SPHK 2 (1 to 654 residues) by ADP Glo HTS assay	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	>	IC50	nM	50000.0	CHEMBL3023	Homo sapiens	IC50	uM	50.0
	18152915	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	IC50	nM	600.0	CHEMBL3023	Homo sapiens	IC50	uM	0.6
	18152916	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCc1ccccc1CC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL4103173	>	IC50	nM	30000.0	CHEMBL3023	Homo sapiens	IC50	uM	30.0
	18152917	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCc1cccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)c1		CHEMBL4078892	=	IC50	nM	2200.0	CHEMBL3023	Homo sapiens	IC50	uM	2.2
	18152918	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCc1cccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)c1		CHEMBL4062604	=	IC50	nM	2100.0	CHEMBL3023	Homo sapiens	IC50	uM	2.1
	18152919	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCc1cccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)c1		CHEMBL4090570	=	IC50	nM	1700.0	CHEMBL3023	Homo sapiens	IC50	uM	1.7
	18152920	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCc1ccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)cc1		CHEMBL4071253	=	IC50	nM	8300.0	CHEMBL3023	Homo sapiens	IC50	uM	8.3
	18152921	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCc1ccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)cc1		CHEMBL4098301	=	IC50	nM	560.0	CHEMBL3023	Homo sapiens	IC50	uM	0.56
	18152922	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCc1ccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)cc1		CHEMBL4081791	=	IC50	nM	670.0	CHEMBL3023	Homo sapiens	IC50	uM	0.67
	18152923	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCc1ccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)cc1		CHEMBL4059874	=	IC50	nM	21000.0	CHEMBL3023	Homo sapiens	IC50	uM	21.0
	18152924	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCCc1ccc(CC[C@@H]2OC[C@@H](N)[C@@H]2O)cc1		CHEMBL4089663	>	IC50	nM	30000.0	CHEMBL3023	Homo sapiens	IC50	uM	30.0
	18152925	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	N[C@@H]1CO[C@@H](CCCCCCCCCCCOCC2CCCCC2)[C@H]1O		CHEMBL4076550	=	IC50	nM	780.0	CHEMBL3023	Homo sapiens	IC50	uM	0.78
	18152926	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	N[C@@H]1CO[C@@H](CCCCCCCCCCOCC2CCCCC2)[C@H]1O		CHEMBL4075031	=	IC50	nM	240.0	CHEMBL3023	Homo sapiens	IC50	uM	0.24
	18152927	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	N[C@@H]1CO[C@@H](CCCCCCCCCOCC2CCCCC2)[C@H]1O		CHEMBL4101713	=	IC50	nM	460.0	CHEMBL3023	Homo sapiens	IC50	uM	0.46
	18152928	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	N[C@@H]1CO[C@@H](CCCCCCCCOCC2CCCCC2)[C@H]1O		CHEMBL4095076	=	IC50	nM	1300.0	CHEMBL3023	Homo sapiens	IC50	uM	1.3
	18152929	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CC(C)COCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL4067667	=	IC50	nM	840.0	CHEMBL3023	Homo sapiens	IC50	uM	0.84
	18152930	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCOCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL4102840	=	IC50	nM	3900.0	CHEMBL3023	Homo sapiens	IC50	uM	3.9
	18152931	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCOCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL4078560	>	IC50	nM	30000.0	CHEMBL3023	Homo sapiens	IC50	uM	30.0
	18152932	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](NC(=N)N)[C@@H]1O		CHEMBL4079512	=	IC50	nM	1900.0	CHEMBL3023	Homo sapiens	IC50	uM	1.9
	18152933	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](NC(C)=N)[C@@H]1O		CHEMBL4097546	=	IC50	nM	9400.0	CHEMBL3023	Homo sapiens	IC50	uM	9.4
	18152934	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](NC(C)=O)[C@@H]1O		CHEMBL4087389	>	IC50	nM	30000.0	CHEMBL3023	Homo sapiens	IC50	uM	30.0
	18152935	CHEMBL4034226	Inhibition of recombinant N-terminal GST-tagged human SphK2 (1 to 618 residues) expressed in baculovirus expression system using sphingosine as substrate after 1 hr in presence of ATP by off-chip mobility shift assay	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1OC		CHEMBL4105246	>	IC50	nM	30000.0	CHEMBL3023	Homo sapiens	IC50	uM	30.0
	18152940	CHEMBL4034228	Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	IC50	nM	20000.0	CHEMBL3023	Homo sapiens	IC50	uM	20.0
	18152941	CHEMBL4034228	Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	IC50	nM	20000.0	CHEMBL3023	Homo sapiens	IC50	uM	20.0
	18152942	CHEMBL4034228	Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method	B	CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1		CHEMBL1526855	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	18152943	CHEMBL4034228	Inhibition of recombinant human SphK2 using NBD-sphingosine as substrate after 2 hrs in presence of ATP by HPLC method	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	IC50	nM	60000.0	CHEMBL3023	Homo sapiens	IC50	uM	60.0
	18152945	CHEMBL4034230	Inhibition of human recombinant C-terminal His6 tagged SphK2 expressed in baculovirus infected sf21 cells using FITC-sphingosine as substrate after 1 hr in presence of ATP by microfluidic capillary electrophoresis mobility shift assay	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	IC50	nM	360.0	CHEMBL3023	Homo sapiens	IC50	uM	0.36
	18152949	CHEMBL4034234	Inhibition of human SphK2 using sphingosine as substrate in presence of [gamma-32P]ATP	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	IC50	nM	4300.0	CHEMBL3023	Homo sapiens	IC50	uM	4.3
	18152951	CHEMBL4034236	Inhibition of human SphK2 using sphingosine as substrate after 15 to 20 mins in presence of [gamma-32P]ATP by Cerenkov counting method	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	IC50	nM	27000.0	CHEMBL3023	Homo sapiens	IC50	uM	27.0
	18152953	CHEMBL4034238	Inhibition of recombinant human SphK2 expressed in baculovirus infected sf9 cells using D-erythro-sphingosine as substrate after 20 mins in presence of gamma-[32P]ATP by autoradiography based TLC analysis	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCN3C(=N)N)n2)cc1		CHEMBL3546876	=	Ki	nM	1200.0	CHEMBL3023	Homo sapiens	Ki	uM	1.2
Not Active	18161879	CHEMBL4036009	Inhibition of human SPHK 2 (1 to 654 residues) at 50 uM by ADP Glo HTS assay	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)c(C)nc2N)n(C)n1		CHEMBL4072637		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	18238820	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccccc4)cs3)cc2)no1		CHEMBL4065206	=	Activity	%	83.0	CHEMBL3023	Homo sapiens	Activity	%	83.0
	18238821	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccncc4)cs3)cc2)no1.O=C(O)C(F)(F)F		CHEMBL4096244	=	Activity	%	94.0	CHEMBL3023	Homo sapiens	Activity	%	94.0
	18238822	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccnc4)cs3)cc2)no1		CHEMBL4068973	=	Activity	%	94.0	CHEMBL3023	Homo sapiens	Activity	%	94.0
	18238823	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(F)cc4)cs3)cc2)no1		CHEMBL4104493	=	Activity	%	55.0	CHEMBL3023	Homo sapiens	Activity	%	55.0
	18238824	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(Cl)cc4)cs3)cc2)no1		CHEMBL4086602	=	Activity	%	51.0	CHEMBL3023	Homo sapiens	Activity	%	51.0
	18238825	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(Br)cc4)cs3)cc2)no1		CHEMBL4066847	=	Activity	%	46.0	CHEMBL3023	Homo sapiens	Activity	%	46.0
	18238826	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(F)c4)cs3)cc2)no1		CHEMBL4094348	=	Activity	%	45.0	CHEMBL3023	Homo sapiens	Activity	%	45.0
	18238827	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(Cl)c4)cs3)cc2)no1		CHEMBL4089078	=	Activity	%	45.0	CHEMBL3023	Homo sapiens	Activity	%	45.0
	18238828	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(Br)c4)cs3)cc2)no1		CHEMBL4071933	=	Activity	%	44.0	CHEMBL3023	Homo sapiens	Activity	%	44.0
	18238829	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccccc4F)cs3)cc2)no1		CHEMBL4096779	=	Activity	%	44.0	CHEMBL3023	Homo sapiens	Activity	%	44.0
	18238830	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cc2)no1		CHEMBL4076479	=	Activity	%	36.0	CHEMBL3023	Homo sapiens	Activity	%	36.0
	18238831	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808	=	Activity	%	28.0	CHEMBL3023	Homo sapiens	Activity	%	28.0
	18238832	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccccc4C(F)(F)F)cs3)cc2)no1		CHEMBL4099036	=	Activity	%	72.0	CHEMBL3023	Homo sapiens	Activity	%	72.0
	18238833	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1.Cl		CHEMBL4076943	=	Activity	%	80.0	CHEMBL3023	Homo sapiens	Activity	%	80.0
	18238834	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	COc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1.Cl		CHEMBL4103765	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	18238835	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	CCOc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1.Cl		CHEMBL4075583	=	Activity	%	84.0	CHEMBL3023	Homo sapiens	Activity	%	84.0
	18238836	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	COc1cccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)c1.Cl		CHEMBL4099373	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	18238837	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(OC(F)(F)F)cc4)cs3)cc2)no1		CHEMBL4093841	=	Activity	%	44.0	CHEMBL3023	Homo sapiens	Activity	%	44.0
	18238838	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(OC(F)(F)F)c4)cs3)cc2)no1		CHEMBL4067076	=	Activity	%	82.0	CHEMBL3023	Homo sapiens	Activity	%	82.0
	18238839	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1C.Cl		CHEMBL4097342	=	Activity	%	67.0	CHEMBL3023	Homo sapiens	Activity	%	67.0
	18238840	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	COc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1OC.Cl		CHEMBL4062200	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	18238841	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	COc1ccc(-c2csc(Nc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)n2)cc1Cl.Cl		CHEMBL4085330	=	Activity	%	71.0	CHEMBL3023	Homo sapiens	Activity	%	71.0
	18238842	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(F)c(F)c4)cs3)cc2)no1		CHEMBL4063729	=	Activity	%	51.0	CHEMBL3023	Homo sapiens	Activity	%	51.0
	18238843	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(Cl)c(Cl)c4)cs3)cc2)no1		CHEMBL4098774	=	Activity	%	46.0	CHEMBL3023	Homo sapiens	Activity	%	46.0
	18238844	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(F)c(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4071762	=	Activity	%	33.0	CHEMBL3023	Homo sapiens	Activity	%	33.0
	18238845	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cc(F)cc(F)c4)cs3)cc2)no1		CHEMBL4060366	=	Activity	%	43.0	CHEMBL3023	Homo sapiens	Activity	%	43.0
	18238846	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cc(F)cc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4082275	=	Activity	%	30.0	CHEMBL3023	Homo sapiens	Activity	%	30.0
	18238847	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4069053	=	Activity	%	63.0	CHEMBL3023	Homo sapiens	Activity	%	63.0
	18238848	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cc(C(F)(F)F)ccc4F)cs3)cc2)no1		CHEMBL4090121	=	Activity	%	48.0	CHEMBL3023	Homo sapiens	Activity	%	48.0
	18238849	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccccc5)cc4)cs3)cc2)no1		CHEMBL4074731	=	Activity	%	27.0	CHEMBL3023	Homo sapiens	Activity	%	27.0
	18238850	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(-c5ccccc5)c4)cs3)cc2)no1		CHEMBL4073731	=	Activity	%	73.0	CHEMBL3023	Homo sapiens	Activity	%	73.0
	18238851	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccc(F)cc5)cc4)cs3)cc2)no1		CHEMBL4075878	=	Activity	%	31.0	CHEMBL3023	Homo sapiens	Activity	%	31.0
	18238852	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccc(C(F)(F)F)cc5)cc4)cs3)cc2)no1		CHEMBL4064377	=	Activity	%	96.0	CHEMBL3023	Homo sapiens	Activity	%	96.0
	18238853	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5cccc(C(F)(F)F)c5)cc4)cs3)cc2)no1		CHEMBL4061443	=	Activity	%	85.0	CHEMBL3023	Homo sapiens	Activity	%	85.0
	18238854	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4coc5ccccc45)cs3)cc2)no1		CHEMBL4093070	=	Activity	%	67.0	CHEMBL3023	Homo sapiens	Activity	%	67.0
	18238855	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Oc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cc2)no1		CHEMBL4070105	=	Activity	%	55.0	CHEMBL3023	Homo sapiens	Activity	%	55.0
	18238856	CHEMBL4051830	Inhibition of recombinant human SPHK2 assessed as residual activity at 0.3 uM using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting relative to control	B	CN(c1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1)c1nc(-c2ccc(-c3ccccc3)cc2)cs1		CHEMBL4097425	=	Activity	%	100.0	CHEMBL3023	Homo sapiens	Activity	%	100.0
	18238863	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	CCCCCOc1ccc2cc(-c3noc([C@H]4[C@@H](O)CCN4C(=N)N)n3)ccc2c1		CHEMBL4074878	=	Ki	nM	900.0	CHEMBL3023	Homo sapiens	Ki	uM	0.9
	18238864	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	18238865	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cc2)no1		CHEMBL4076479	=	Ki	nM	390.0	CHEMBL3023	Homo sapiens	Ki	uM	0.39
	18238866	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808	=	Ki	nM	90.0	CHEMBL3023	Homo sapiens	Ki	uM	0.09
	18238867	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(OC(F)(F)F)cc4)cs3)cc2)no1		CHEMBL4093841	=	Ki	nM	250.0	CHEMBL3023	Homo sapiens	Ki	uM	0.25
	18238868	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(F)c(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4071762	=	Ki	nM	170.0	CHEMBL3023	Homo sapiens	Ki	uM	0.17
	18238869	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cc(F)cc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4082275	=	Ki	nM	170.0	CHEMBL3023	Homo sapiens	Ki	uM	0.17
	18238870	CHEMBL4051832	Inhibition of recombinant human SPHK2 at using sphingosine as substrate after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccccc5)cc4)cs3)cc2)no1		CHEMBL4074731	=	Ki	nM	90.0	CHEMBL3023	Homo sapiens	Ki	uM	0.09
Not Active	18238879	CHEMBL4051834	Inhibition of recombinant human SPHK2 using sphingosine as substrate up to 1 uM after 30 mins in presence of gamma-[32P]-ATP by liquid scintillation counting	B	CN(c1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1)c1nc(-c2ccc(-c3ccccc3)cc2)cs1		CHEMBL4097425		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	18238882	CHEMBL4051836	Inhibition of SPHK2 in human U937 cells assessed as decrease in S1P levels after 2 hrs by LC-MS/MS analysis	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	18238883	CHEMBL4051836	Inhibition of SPHK2 in human U937 cells assessed as decrease in S1P levels after 2 hrs by LC-MS/MS analysis	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccccc5)cc4)cs3)cc2)no1		CHEMBL4074731		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	18238886	CHEMBL4051838	Inhibition of SPHK2 in human U937 cells assessed as effect on sphingosine levels at 0.1 to 1 uM after 2 hrs by LC-MS/MS analysis	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	18238887	CHEMBL4051838	Inhibition of SPHK2 in human U937 cells assessed as effect on sphingosine levels at 0.1 to 1 uM after 2 hrs by LC-MS/MS analysis	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccccc5)cc4)cs3)cc2)no1		CHEMBL4074731		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	18238896	CHEMBL4051846	Inhibition of recombinant human SPHK2 expressed in Escherichia coli using [3-3H]sphingosine as substrate after 30 mins by scintillation counting	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	7900.0	CHEMBL3023	Homo sapiens	Ki	uM	7.9
	18238898	CHEMBL4051848	Inhibition of recombinant human SPHK2 using sphingosine as substrate by ADP-Quest assay	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
Active	18238900	CHEMBL4051850	Inhibition of SPHK2 in human U937 cells assessed as effect on sphingosine levels at 0.3 to 1 uM after 2 hrs by LC-MS/MS analysis	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4ccc(-c5ccccc5)cc4)cs3)cc2)no1		CHEMBL4074731		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	18653357	CHEMBL4230227	Inhibition of SPHK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	18653358	CHEMBL4230227	Inhibition of SPHK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	20.0	CHEMBL3023	Homo sapiens	INH	%	20.0
	18751241	CHEMBL4263950	Inhibition of SPHK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	18789030	CHEMBL4272380	Inhibition of SK2 (unknown origin)	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	IC50	nM	20000.0	CHEMBL3023	Homo sapiens	IC50	uM	20.0
	19032381	CHEMBL4349870	Inhibition of SK2 (unknown origin) at 10 using sphingosine as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence based assay relative to control	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Inhibition	%	72.0	CHEMBL3023	Homo sapiens	INH	%	72.0
	19032382	CHEMBL4349870	Inhibition of SK2 (unknown origin) at 10 using sphingosine as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence based assay relative to control	B	Nc1cc(-c2c[nH]c3ncccc23)ccn1		CHEMBL4552170	=	Inhibition	%	39.0	CHEMBL3023	Homo sapiens	INH	%	39.0
	19032383	CHEMBL4349870	Inhibition of SK2 (unknown origin) at 10 using sphingosine as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by fluorescence based assay relative to control	B	Nc1cc(-c2c[nH]c3ncccc23)cc(N)n1		CHEMBL4543363	=	Inhibition	%	87.0	CHEMBL3023	Homo sapiens	INH	%	87.0
	19059019	CHEMBL4357630	Inhibition of recombinant human His6/HA-fusion-tagged SphK2 expressed in baculovirus infected sf9 insect cells using d-erythro-sphingosine as substrate in presence of [gamma32P]-ATP and ATP by radioactivity-based assay	B	Cc1ccc(S(=O)(=O)Nc2ccccc2/C=N/c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1		CHEMBL3764617	=	Ki	nM	6900.0	CHEMBL3023	Homo sapiens	Ki	uM	6.9
	19059027	CHEMBL4357634	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 1 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1C(F)(F)F.Cl		CHEMBL4466524	=	Inhibition	%	80.0	CHEMBL3023	Homo sapiens	INH	%	80.0
	19059028	CHEMBL4357634	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 1 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL4525310	=	Inhibition	%	8.0	CHEMBL3023	Homo sapiens	INH	%	8.0
	19059029	CHEMBL4357634	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 1 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1		CHEMBL4453931	=	Inhibition	%	77.0	CHEMBL3023	Homo sapiens	INH	%	77.0
	19059030	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1C(F)(F)F.Cl		CHEMBL4466524	=	Inhibition	%	51.0	CHEMBL3023	Homo sapiens	INH	%	51.0
	19059031	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL4525310	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	19059032	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1		CHEMBL4453931	=	Inhibition	%	65.0	CHEMBL3023	Homo sapiens	INH	%	65.0
	19059033	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)no1		CHEMBL4535657	=	Inhibition	%	2.0	CHEMBL3023	Homo sapiens	INH	%	2.0
	19059034	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(-c3ccccc3)c2)no1		CHEMBL4589931	=	Inhibition	%	28.0	CHEMBL3023	Homo sapiens	INH	%	28.0
	19059035	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(-c3ccc(F)cc3)c2)no1		CHEMBL4532872	=	Inhibition	%	31.0	CHEMBL3023	Homo sapiens	INH	%	31.0
	19059036	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(-c3ccncc3)c2)no1		CHEMBL4520434	=	Inhibition	%	8.0	CHEMBL3023	Homo sapiens	INH	%	8.0
	19059037	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(-c3ccc(C(F)(F)F)cc3)c2)no1		CHEMBL4555733	=	Inhibition	%	12.0	CHEMBL3023	Homo sapiens	INH	%	12.0
	19059038	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(Br)c2)no1		CHEMBL4469195	=	Inhibition	%	24.0	CHEMBL3023	Homo sapiens	INH	%	24.0
	19059039	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(Cl)c2)no1		CHEMBL4459966	=	Inhibition	%	33.0	CHEMBL3023	Homo sapiens	INH	%	33.0
	19059040	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(F)c2)no1		CHEMBL4548799	=	Inhibition	%	23.0	CHEMBL3023	Homo sapiens	INH	%	23.0
	19059041	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)cc2Cl)no1		CHEMBL4474577	=	Inhibition	%	40.0	CHEMBL3023	Homo sapiens	INH	%	40.0
	19059042	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)cc2C(F)(F)F)no1		CHEMBL4457640	=	Inhibition	%	35.0	CHEMBL3023	Homo sapiens	INH	%	35.0
	19059043	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c([N+](=O)[O-])c2)no1		CHEMBL4451322	=	Inhibition	%	33.0	CHEMBL3023	Homo sapiens	INH	%	33.0
	19059044	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	COc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4526820	=	Inhibition	%	15.0	CHEMBL3023	Homo sapiens	INH	%	15.0
	19059045	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc(C)c1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4468658	=	Inhibition	%	23.0	CHEMBL3023	Homo sapiens	INH	%	23.0
	19059046	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4462917	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	19059047	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4466495	=	Inhibition	%	42.0	CHEMBL3023	Homo sapiens	INH	%	42.0
	19059048	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CCCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4462152	=	Inhibition	%	60.0	CHEMBL3023	Homo sapiens	INH	%	60.0
	19059049	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	C=CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4473353	=	Inhibition	%	59.0	CHEMBL3023	Homo sapiens	INH	%	59.0
	19059050	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CC(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4593983	=	Inhibition	%	67.0	CHEMBL3023	Homo sapiens	INH	%	67.0
	19059051	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C3CC3)c2)no1		CHEMBL4456325	=	Inhibition	%	52.0	CHEMBL3023	Homo sapiens	INH	%	52.0
	19059052	CHEMBL4357635	Inhibition of recombinant human SphK2 transfected in HEK293T cells at 0.3 uM using D-erythro-sphingosine as substrate incubated for 20 mins in presence of [gamma32P]-ATP by liquid scintillation counting method relative to control	B	CC(C)(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4570134	=	Inhibition	%	66.0	CHEMBL3023	Homo sapiens	INH	%	66.0
	19059060	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1		CHEMBL4453931	=	EC50	nM	59.0	CHEMBL3023	Homo sapiens	EC50	nM	59.0
	19059061	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4466495	=	EC50	nM	146.0	CHEMBL3023	Homo sapiens	EC50	nM	146.0
	19059062	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	CCCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4462152	=	EC50	nM	37.0	CHEMBL3023	Homo sapiens	EC50	nM	37.0
	19059063	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	C=CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4473353	=	EC50	nM	84.0	CHEMBL3023	Homo sapiens	EC50	nM	84.0
	19059064	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	CC(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4593983	=	EC50	nM	32.0	CHEMBL3023	Homo sapiens	EC50	nM	32.0
	19059065	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C3CC3)c2)no1		CHEMBL4456325	=	EC50	nM	50.0	CHEMBL3023	Homo sapiens	EC50	nM	50.0
	19059066	CHEMBL4357638	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth measured after 24 hrs	B	CC(C)(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4570134	=	EC50	nM	73.0	CHEMBL3023	Homo sapiens	EC50	nM	73.0
	19059072	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1		CHEMBL4453931	=	Ki	nM	89.0	CHEMBL3023	Homo sapiens	Ki	nM	89.0
	19059073	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	CCCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4462152	=	Ki	nM	201.0	CHEMBL3023	Homo sapiens	Ki	nM	201.0
	19059074	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	CC(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4593983	=	Ki	nM	192.0	CHEMBL3023	Homo sapiens	Ki	nM	192.0
	19059075	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C3CC3)c2)no1		CHEMBL4456325	=	Ki	nM	186.0	CHEMBL3023	Homo sapiens	Ki	nM	186.0
	19059076	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	CC(C)(C)c1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl		CHEMBL4570134	=	Ki	nM	197.0	CHEMBL3023	Homo sapiens	Ki	nM	197.0
	19059087	CHEMBL4357639	Inhibition of recombinant human SphK2 expressed in baculovirus infected Sf9 cells assessed as decrease in [33P]S1P production using varying level of D-erythro-sphingosine as substrate in presence of [gamma33P]-ATP by scintillation proximity assay	B	CCCCCCCCOc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1C(F)(F)F.Cl		CHEMBL4466524	=	Ki	nM	370.0	CHEMBL3023	Homo sapiens	Ki	nM	370.0
	19206006	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	>	IC50	nM	5000.0	CHEMBL3023	Homo sapiens	IC50	nM	5000.0
	19206007	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	O=S(=O)(Oc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1)c1ccccc1		CHEMBL4444218	=	IC50	nM	902.0	CHEMBL3023	Homo sapiens	IC50	nM	902.0
	19206008	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(CCc3ccccc3)c2)cc1		CHEMBL4472026	=	IC50	nM	35.0	CHEMBL3023	Homo sapiens	IC50	nM	35.0
	19206009	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3ccccc3)c2)cc1		CHEMBL4574678	=	IC50	nM	16.0	CHEMBL3023	Homo sapiens	IC50	nM	16.0
	19206010	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3ccccc3F)c2)cc1		CHEMBL4551903	=	IC50	nM	55.0	CHEMBL3023	Homo sapiens	IC50	nM	55.0
	19206011	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3cccc(F)c3)c2)cc1		CHEMBL4474024	=	IC50	nM	143.0	CHEMBL3023	Homo sapiens	IC50	nM	143.0
	19206012	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3ccc(F)cc3)c2)cc1		CHEMBL4456309	=	IC50	nM	49.0	CHEMBL3023	Homo sapiens	IC50	nM	49.0
	19206013	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3ccccc3Cl)c2)cc1		CHEMBL4454855	=	IC50	nM	151.0	CHEMBL3023	Homo sapiens	IC50	nM	151.0
	19206014	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3cccc(Cl)c3)c2)cc1		CHEMBL4455113	=	IC50	nM	412.0	CHEMBL3023	Homo sapiens	IC50	nM	412.0
	19206015	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(OCc3ccc(Cl)cc3)c2)cc1		CHEMBL4551657	=	IC50	nM	41.0	CHEMBL3023	Homo sapiens	IC50	nM	41.0
	19206016	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	COc1ccc(COc2cccc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c2)cc1		CHEMBL4448423	=	IC50	nM	119.0	CHEMBL3023	Homo sapiens	IC50	nM	119.0
	19206017	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	N#Cc1ccc(COc2cccc(OCc3ccc(CN4CCC[C@@H]4CO)cc3)c2)cc1		CHEMBL4555776	=	IC50	nM	1120.0	CHEMBL3023	Homo sapiens	IC50	uM	1.12
	19206018	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(SCc3ccccc3)c2)cc1		CHEMBL4578165	=	IC50	nM	26.0	CHEMBL3023	Homo sapiens	IC50	nM	26.0
	19206019	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(SCc3ccc(F)cc3)c2)cc1		CHEMBL4593030	=	IC50	nM	17.0	CHEMBL3023	Homo sapiens	IC50	nM	17.0
	19206020	CHEMBL4392251	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	OC[C@H]1CCCN1Cc1ccc(COc2cccc(SCc3ccc(Cl)cc3)c2)cc1		CHEMBL4453199	=	IC50	nM	31.0	CHEMBL3023	Homo sapiens	IC50	nM	31.0
	19206021	CHEMBL4392252	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells at 5 uM using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	33.0	CHEMBL3023	Homo sapiens	INH	%	33.0
	19206022	CHEMBL4392253	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells at 3 uM using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis relative to control	B	O=S(=O)(Cc1cccc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1)c1ccccc1		CHEMBL4090361	=	Inhibition	%	16.0	CHEMBL3023	Homo sapiens	INH	%	16.0
	19206038	CHEMBL4392255	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells using NBD-Sph as substrate measured after 2 hrs by fluorescence based HPLC analysis	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	nM	9800.0
	19206039	CHEMBL4392256	Inhibition of SK2 (unknown origin) expressed in cell lysates using Sph as substrate measured in presence of [gamma32P]ATP	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	nM	6400.0
	19206041	CHEMBL4392258	Inhibition of recombinant SK2 (unknown origin) expressed in Sf9 insect cells using D-erythro-sphingosine as substrate measured in presence of [gamma32P]ATP by scintillation proximity assay	B	CCCCCCCCc1ccc(-c2noc([C@@H]3CCCN3C(=N)N)n2)cc1		CHEMBL3086782	=	Ki	nM	1300.0	CHEMBL3023	Homo sapiens	Ki	nM	1300.0
	19206042	CHEMBL4392259	Inhibition of purified SK2 (unknown origin) using Sph as substrate measured after 15 to 20 mins in presence of [gamma32P]ATP by Cerenkov counting analysis	B	CCCCCCCCc1ccc(CC[C@](N)(CO)OC)cc1		CHEMBL1927600	=	Ki	nM	16000.0	CHEMBL3023	Homo sapiens	Ki	nM	16000.0
	19206044	CHEMBL4392261	Inhibition of SK2 (unknown origin)	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Ki	nM	3.6	CHEMBL3023	Homo sapiens	Ki	nM	3.6
	19206045	CHEMBL4392261	Inhibition of SK2 (unknown origin)	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	6700.0	CHEMBL3023	Homo sapiens	Ki	nM	6700.0
	19206046	CHEMBL4392262	Inhibition of recombinant human full-length N-terminal His-tagged SK2 expressed in baculovirus infected Sf9 insect cells at 50 uM using Sph as substrate measured after 30 mins in presence of [gamma32P]ATP by Cerenkov counting analysis relative to control	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	Inhibition	%	72.0	CHEMBL3023	Homo sapiens	INH	%	72.0
	19266180	CHEMBL4405187	Inhibition of human SPHK2 at 1 uM using sphingosine as substrate in presence of 10 uM ATP by ADP-Glo assay relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	=	Inhibition	%	2.0	CHEMBL3023	Homo sapiens	INH	%	2.0
	19474699	CHEMBL4479388	Inhibition of SPHK2 (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL3023	Homo sapiens	pIC50		5.0
	20600672	CHEMBL4603624	Inhibition of recombinant full length GST-tagged human SPHK2 expressed in baculovirus expression system using Sphingosine lipid as substrate in presence of ATP after 1 hr by Adapta assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	20697596	CHEMBL4627180	Drug metabolism in human assessed as SphK2-mediated compound phosphorylation by measuring ratio of phosphorylated compound to parent compound measured after 24 hrs	A	CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1		CHEMBL3806158	=	Ratio		0.1	CHEMBL3023	Homo sapiens	Ratio		0.1
	20697597	CHEMBL4627180	Drug metabolism in human assessed as SphK2-mediated compound phosphorylation by measuring ratio of phosphorylated compound to parent compound measured after 24 hrs	A	COc1ccccc1CC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1		CHEMBL4649457	=	Ratio		0.6	CHEMBL3023	Homo sapiens	Ratio		0.6
Not Determined	20697598	CHEMBL4627180	Drug metabolism in human assessed as SphK2-mediated compound phosphorylation by measuring ratio of phosphorylated compound to parent compound measured after 24 hrs	A	COc1cccc(OC[C@@H]2CCc3cc([C@H]4CC[C@](N)(CO)C4)ccc3C2)c1		CHEMBL4643014		Ratio			CHEMBL3023	Homo sapiens	Ratio		
Not Active	22399421	CHEMBL4669269	Inhibition of SphK2 (unknown origin) catalytic activity at 2 to 5 uM	B	COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1		CHEMBL552462		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Active	22399425	CHEMBL4669273	Binding affinity to SphK2 in HEK293 cells assessed as induction of thermal stabilization at 1 uM and 48.8 to 68.2 degreeC by CETSA-based Western blot analysis	B	COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1		CHEMBL552462		Activity			CHEMBL3023	Homo sapiens	Activity		
	22399429	CHEMBL4669277	Binding affinity to SphK2 in HEK293 cells assessed as direct target engagement incubated for 24 hrs followed by thermal denaturation at 61 degreeC by ITDRF-CETSA assay	B	COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1		CHEMBL552462	=	IC50	nM	60.0	CHEMBL3023	Homo sapiens	IC50	nM	60.0
	22487270	CHEMBL4689033	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth at 30 degreeC measured after 24 to 48 hrs	B	CCCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4763909	=	EC50	nM	290.0	CHEMBL3023	Homo sapiens	EC50	nM	290.0
	22487271	CHEMBL4689033	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth at 30 degreeC measured after 24 to 48 hrs	B	CCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4754696	=	EC50	nM	246.0	CHEMBL3023	Homo sapiens	EC50	nM	246.0
	22487272	CHEMBL4689033	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth at 30 degreeC measured after 24 to 48 hrs	B	CCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4783140	=	EC50	nM	401.0	CHEMBL3023	Homo sapiens	EC50	nM	401.0
	22487273	CHEMBL4689033	Inhibition of human SphK2 expressed in Saccharomyces cerevisiae KYA1 assessed as yeast growth at 30 degreeC measured after 24 to 48 hrs	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1		CHEMBL4743459	=	EC50	nM	488.0	CHEMBL3023	Homo sapiens	EC50	nM	488.0
	22487304	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCc1ccc(C#Cc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4740077	=	Inhibition	%	19.0	CHEMBL3023	Homo sapiens	INH	%	19.0
	22487305	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCc1ccc(C#Cc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4792869	=	Inhibition	%	25.0	CHEMBL3023	Homo sapiens	INH	%	25.0
	22487306	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCc1ccc(C#Cc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4743805	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487307	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCc1ccc(CCc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4779419	=	Inhibition	%	13.0	CHEMBL3023	Homo sapiens	INH	%	13.0
	22487308	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCc1ccc(CCc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4782258	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487309	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCc1ccc(CCc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4761646	=	Inhibition	%	15.0	CHEMBL3023	Homo sapiens	INH	%	15.0
	22487310	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(/C=C/c2cccc(C(F)(F)F)c2)cc1		CHEMBL4782103	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487311	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cc1cc(/C=C/c2ccc(C(C)(C)C)cc2)ccc1CN1CCC[C@@H]1CO.Cl		CHEMBL4780544	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	22487312	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCCc1ccc(CN2CCC[C@@H]2COC(C)=O)cc1.Cl		CHEMBL4744449	=	Inhibition	%	2.0	CHEMBL3023	Homo sapiens	INH	%	2.0
	22487313	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	COc1ccc(CCc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4800321	=	Inhibition	%	3.0	CHEMBL3023	Homo sapiens	INH	%	3.0
	22487314	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(CCc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4782965	=	Inhibition	%	26.0	CHEMBL3023	Homo sapiens	INH	%	26.0
	22487315	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)c(C)c1.Cl		CHEMBL4750421	=	Inhibition	%	38.0	CHEMBL3023	Homo sapiens	INH	%	38.0
	22487316	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4763909	=	Inhibition	%	37.0	CHEMBL3023	Homo sapiens	INH	%	37.0
	22487317	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4754696	=	Inhibition	%	18.0	CHEMBL3023	Homo sapiens	INH	%	18.0
	22487318	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4783140	=	Inhibition	%	54.0	CHEMBL3023	Homo sapiens	INH	%	54.0
	22487319	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4745525	=	Inhibition	%	44.0	CHEMBL3023	Homo sapiens	INH	%	44.0
	22487320	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL4761630	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487321	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1		CHEMBL4743459	=	Inhibition	%	52.0	CHEMBL3023	Homo sapiens	INH	%	52.0
	22487322	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2cccc(-c3ccc(C(F)(F)F)cc3)c2)cc1		CHEMBL4746744	=	Inhibition	%	1.0	CHEMBL3023	Homo sapiens	INH	%	1.0
	22487323	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2cccc(-c3cccc(C(F)(F)F)c3)c2)cc1		CHEMBL4764000	=	Inhibition	%	11.0	CHEMBL3023	Homo sapiens	INH	%	11.0
	22487324	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1		CHEMBL4786637	=	Inhibition	%	9.0	CHEMBL3023	Homo sapiens	INH	%	9.0
	22487325	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2cccc(-c3ccccc3)c2)cc1		CHEMBL4752295	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487326	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CC(C)(C)c1ccc(Oc2ccc(CN3CCC[C@@H]3CO)cc2)cc1.Cl		CHEMBL4750610	=	Inhibition	%	22.0	CHEMBL3023	Homo sapiens	INH	%	22.0
	22487327	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CC(C)(C)c1cccc(Oc2ccc(CN3CCC[C@@H]3CO)cc2)c1.Cl		CHEMBL4753101	=	Inhibition	%	11.0	CHEMBL3023	Homo sapiens	INH	%	11.0
	22487328	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(Oc2ccccc2)cc1		CHEMBL4785462	=	Inhibition	%	13.0	CHEMBL3023	Homo sapiens	INH	%	13.0
	22487329	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	Cl.OC[C@H]1CCCN1Cc1ccc(OCc2ccc(C(F)(F)F)cc2)cc1		CHEMBL4755505	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487330	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCCOc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4748553	=	Inhibition	%	11.0	CHEMBL3023	Homo sapiens	INH	%	11.0
	22487331	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCCOc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4788097	=	Inhibition	%	44.0	CHEMBL3023	Homo sapiens	INH	%	44.0
	22487332	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCCOc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4784133	=	Inhibition	%	1.0	CHEMBL3023	Homo sapiens	INH	%	1.0
	22487333	CHEMBL4689035	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production at 0.3 uM using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method relative to control	B	CCCCCCCOc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4762856	=	Inhibition	%	0.0	CHEMBL3023	Homo sapiens	INH	%	0.0
	22487341	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	CCCCCCCCCCCCc1ccc(CN2CCC[C@@H]2CO)cc1.Cl		CHEMBL4763909	=	Ki	nM	951.0	CHEMBL3023	Homo sapiens	Ki	nM	951.0
	22487342	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Ki	nM	7900.0	CHEMBL3023	Homo sapiens	Ki	uM	7.9
	22487343	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	Cc1ccc(S(=O)(=O)Nc2ccccc2/C=N/c2ccccc2NS(=O)(=O)c2ccc(C)cc2)cc1		CHEMBL3764617	=	Ki	nM	6900.0	CHEMBL3023	Homo sapiens	Ki	uM	6.9
	22487344	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	CCCCCCCCOc1ccc(COc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc2C(F)(F)F)cc1.Cl		CHEMBL4799862	=	Ki	nM	400.0	CHEMBL3023	Homo sapiens	Ki	uM	0.4
	22487345	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(OCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1		CHEMBL4453931	=	Ki	nM	89.0	CHEMBL3023	Homo sapiens	Ki	uM	0.08900000000000001
	22487346	CHEMBL4689037	Inhibition of recombinant human SphK2 assessed as decrease in [33P]SIP production using sphingosine as substrate in presence of [gamma33P]-ATP by scintillation counting method	B	CCCCCCCCc1ccc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)cc1.Cl		CHEMBL3416846	>	Ki	nM	10000.0	CHEMBL3023	Homo sapiens	Ki	uM	10.0
	22795849	CHEMBL4710636	Inhibition of recombinant human Flag-tagged SphK2 transfected in HEK293 cells using d-erythro-sphingosine as substrate by [gamma32P]-ATP based assay	B	Cc1ccc(S(=O)(=O)Nc2cccc(/C=N/c3ccccc3NS(=O)(=O)c3ccc(C)cc3)c2)cc1		CHEMBL4748833	=	Ki	nM	6900.0	CHEMBL3023	Homo sapiens	Ki	uM	6.9
	22795852	CHEMBL4710639	Inhibition of recombinant human N-terminal His-tagged full length SphK2 expressed in baculovirus infected Sf9 cells using C17-sphingosine as substrate incubated for 2 hrs by ADQ Quest assay	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	uM	9.8
	22795853	CHEMBL4710640	Inhibition of recombinant SphK2 (unknown origin) using sphingosine as substrate by [gamma32P]-ATP based assay	B	CCCCOc1ccc(CC/C=C2\SC(=O)N(CCN)C2=O)cc1		CHEMBL3287036	=	Ki	nM	6400.0	CHEMBL3023	Homo sapiens	Ki	uM	6.4
	22795854	CHEMBL4710641	Inhibition of recombinant SphK2 (unknown origin) using sphingosine as substrate incubated for 15 to 20 mins by [gamma32P]-ATP based assay	B	CCCCCCCCc1ccc(CC[C@@](N)(CO)COC)cc1		CHEMBL2158686	=	Ki	nM	16500.0	CHEMBL3023	Homo sapiens	Ki	uM	16.5
	22795855	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795856	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)no1		CHEMBL4790566	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795857	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Cn3cc(-c4ccccn4)nn3)cc2)no1		CHEMBL4758134	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795858	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	COc1ccc(-c2cn(Cc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cc1.Cl		CHEMBL4788185	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795859	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.Cn1cc(-c2cn(Cc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cn1		CHEMBL4759664	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795860	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)no1		CHEMBL4787566	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795861	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)no1		CHEMBL4786788	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795862	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccccn4)nn3)cc2)no1		CHEMBL4744487	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795863	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	COc1ccc(-c2cn(Cc3ccc(-c4noc([C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cc1.Cl		CHEMBL4740722	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795864	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4cccs4)nn3)cc2)no1		CHEMBL4795313	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795865	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	CCCCc1cn(Cc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc2)nn1.Cl		CHEMBL4746451	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795866	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccc(F)cc4)nn3)cc2)no1		CHEMBL4754272	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795867	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(C4CC4)nn3)cc2)no1		CHEMBL4784819	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795868	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)C1(c2nc(-c3ccc(Cn4cc(-c5ccccc5)nn4)cc3)no2)CC1		CHEMBL4753468	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795869	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.Cn1cc(-c2cn(Cc3ccc(-c4noc(C5(C(=N)N)CC5)n4)cc3)nn2)cn1		CHEMBL4798501	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795870	CHEMBL4710642	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells at 125 uM using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay relative to control	B	Cl.N=C(N)C1(c2nc(-c3ccc(Cn4cc(C5CC5)nn4)cc3)no2)CC1		CHEMBL4740413	>	Inhibition	%	50.0	CHEMBL3023	Homo sapiens	INH	%	50.0
	22795890	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Nc3nc(-c4cccc(C(F)(F)F)c4)cs3)cc2)no1		CHEMBL4076808	=	IC50	nM	280.0	CHEMBL3023	Homo sapiens	IC50	uM	0.28
	22795891	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)no1		CHEMBL4790566	=	IC50	nM	396.0	CHEMBL3023	Homo sapiens	IC50	uM	0.396
	22795892	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1Cc1nc(-c2ccc(Cn3cc(-c4ccccn4)nn3)cc2)no1		CHEMBL4758134	=	IC50	nM	452.0	CHEMBL3023	Homo sapiens	IC50	uM	0.452
	22795893	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2cn(Cc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cc1.Cl		CHEMBL4788185	=	IC50	nM	640.0	CHEMBL3023	Homo sapiens	IC50	uM	0.64
	22795894	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.Cn1cc(-c2cn(Cc3ccc(-c4noc(C[C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cn1		CHEMBL4759664	=	IC50	nM	234.0	CHEMBL3023	Homo sapiens	IC50	uM	0.23399999999999999
	22795895	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)no1		CHEMBL4786788	=	IC50	nM	359.0	CHEMBL3023	Homo sapiens	IC50	uM	0.359
	22795896	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccccn4)nn3)cc2)no1		CHEMBL4744487	=	IC50	nM	909.0	CHEMBL3023	Homo sapiens	IC50	uM	0.909
	22795897	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	COc1ccc(-c2cn(Cc3ccc(-c4noc([C@@H]5CCCN5C(=N)N)n4)cc3)nn2)cc1.Cl		CHEMBL4740722	=	IC50	nM	266.0	CHEMBL3023	Homo sapiens	IC50	uM	0.266
	22795898	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4cccs4)nn3)cc2)no1		CHEMBL4795313	=	IC50	nM	687.0	CHEMBL3023	Homo sapiens	IC50	uM	0.687
	22795899	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	CCCCc1cn(Cc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc2)nn1.Cl		CHEMBL4746451	=	IC50	nM	254.0	CHEMBL3023	Homo sapiens	IC50	uM	0.254
	22795900	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(-c4ccc(F)cc4)nn3)cc2)no1		CHEMBL4754272	=	IC50	nM	391.0	CHEMBL3023	Homo sapiens	IC50	uM	0.391
	22795901	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc(Cn3cc(C4CC4)nn3)cc2)no1		CHEMBL4784819	=	IC50	nM	248.0	CHEMBL3023	Homo sapiens	IC50	uM	0.248
	22795902	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)C1(c2nc(-c3ccc(Cn4cc(-c5ccccc5)nn4)cc3)no2)CC1		CHEMBL4753468	=	IC50	nM	261.0	CHEMBL3023	Homo sapiens	IC50	uM	0.261
	22795903	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.Cn1cc(-c2cn(Cc3ccc(-c4noc(C5(C(=N)N)CC5)n4)cc3)nn2)cn1		CHEMBL4798501	=	IC50	nM	269.0	CHEMBL3023	Homo sapiens	IC50	uM	0.26899999999999996
	22795904	CHEMBL4710644	Inhibition of recombinant human N-terminal His-tagged SphK2 (2 to 654 residues) expressed in baculovirus infected Sf21 cells using d-erythro-sphingosine as substrate incubated for 1 hr by ADP-Glo assay	B	Cl.N=C(N)C1(c2nc(-c3ccc(Cn4cc(C5CC5)nn4)cc3)no2)CC1		CHEMBL4740413	=	IC50	nM	717.0	CHEMBL3023	Homo sapiens	IC50	uM	0.7170000000000001
	22853816	CHEMBL4724335	Inhibition of SphK2 (unknown origin)	B	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1		CHEMBL3134157	=	IC50	nM	5400.0	CHEMBL3023	Homo sapiens	IC50	uM	5.4
	22853817	CHEMBL4724335	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCCCCCCC[C@H]1NC[C@H](N)[C@@H]1O.Cl.Cl		CHEMBL4777051	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	22853818	CHEMBL4724335	Inhibition of SphK2 (unknown origin)	B	CCCCCCCCCCCCCC[C@H]1NC[C@H](N)[C@@H]1O		CHEMBL4756733	>	IC50	nM	100000.0	CHEMBL3023	Homo sapiens	IC50	uM	100.0
	22919130	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814580	=	Activity	%	95.0	CHEMBL3023	Homo sapiens	Activity	%	95.0
	22919131	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4744495	=	Activity	%	96.0	CHEMBL3023	Homo sapiens	Activity	%	96.0
	22919132	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4798233	=	Activity	%	73.0	CHEMBL3023	Homo sapiens	Activity	%	73.0
	22919133	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4747145	=	Activity	%	59.0	CHEMBL3023	Homo sapiens	Activity	%	59.0
	22919134	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4755938	=	Activity	%	47.0	CHEMBL3023	Homo sapiens	Activity	%	47.0
	22919135	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4798982	=	Activity	%	79.0	CHEMBL3023	Homo sapiens	Activity	%	79.0
	22919136	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4783605	=	Activity	%	46.0	CHEMBL3023	Homo sapiens	Activity	%	46.0
	22919137	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCn1ccc2c(-c3noc([C@@H]4CCCN4C(=N)N)n3)cccc21.Cl		CHEMBL4742083	=	Activity	%	89.0	CHEMBL3023	Homo sapiens	Activity	%	89.0
	22919138	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCn1ccc2c(-c3noc([C@@H]4CCCN4C(=N)N)n3)cccc21.Cl		CHEMBL4751887	=	Activity	%	84.0	CHEMBL3023	Homo sapiens	Activity	%	84.0
	22919139	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCn1ccc2c(-c3noc([C@@H]4CCCN4C(=N)N)n3)cccc21.Cl		CHEMBL4798348	=	Activity	%	68.0	CHEMBL3023	Homo sapiens	Activity	%	68.0
	22919140	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCn1ccc2c(-c3noc([C@@H]4CCCN4C(=N)N)n3)cccc21.Cl		CHEMBL4781041	=	Activity	%	64.0	CHEMBL3023	Homo sapiens	Activity	%	64.0
	22919141	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4755500	=	Activity	%	72.0	CHEMBL3023	Homo sapiens	Activity	%	72.0
	22919142	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4761712	=	Activity	%	93.0	CHEMBL3023	Homo sapiens	Activity	%	93.0
	22919143	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4777047	=	Activity	%	87.0	CHEMBL3023	Homo sapiens	Activity	%	87.0
	22919144	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4750447	=	Activity	%	25.0	CHEMBL3023	Homo sapiens	Activity	%	25.0
	22919145	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4782021	=	Activity	%	31.0	CHEMBL3023	Homo sapiens	Activity	%	31.0
	22919146	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCn1ccc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc21.Cl		CHEMBL4752686	=	Activity	%	103.0	CHEMBL3023	Homo sapiens	Activity	%	103.0
	22919147	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCn1ccc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc21.Cl		CHEMBL4752741	=	Activity	%	93.0	CHEMBL3023	Homo sapiens	Activity	%	93.0
	22919148	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCn1ccc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc21.Cl		CHEMBL4781511	=	Activity	%	79.0	CHEMBL3023	Homo sapiens	Activity	%	79.0
	22919149	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCCn1ccc2ccc(-c3noc([C@@H]4CCCN4C(=N)N)n3)cc21.Cl		CHEMBL4761243	=	Activity	%	68.0	CHEMBL3023	Homo sapiens	Activity	%	68.0
	22919150	CHEMBL4736173	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 0.3 uM using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis relative to control	B	CCCCCCCCCn1cc(-c2noc(C[C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4797048	=	Activity	%	98.0	CHEMBL3023	Homo sapiens	Activity	%	98.0
	22919157	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	CCCCOc1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc2c1.Cl		CHEMBL3814580	=	Ki	nM	0.98	CHEMBL3023	Homo sapiens	Ki	nM	0.98
	22919158	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	CCCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4755938	=	Ki	nM	0.3	CHEMBL3023	Homo sapiens	Ki	nM	0.3
	22919159	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	CCCCCCCCCCCCn1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)c2ccccc21.Cl		CHEMBL4783605	=	Ki	nM	0.29	CHEMBL3023	Homo sapiens	Ki	nM	0.29
	22919160	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	CCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4750447	=	Ki	nM	0.09	CHEMBL3023	Homo sapiens	Ki	nM	0.09
	22919161	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	CCCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4782021	=	Ki	nM	0.12	CHEMBL3023	Homo sapiens	Ki	nM	0.12
	22919162	CHEMBL4736175	Inhibition of recombinant human Sphk2 expressed in baculovirus infected Sf9 insect cells using d-erythro-sphingosine as substrate measured after 20 mins in presence of [gamma-32P]ATP by liquid scintillation counting analysis	B	Cl.N=C(N)N1CCC[C@H]1c1nc(-c2ccc3cc(OCc4ccc(C(F)(F)F)cc4)ccc3c2)no1		CHEMBL3814849	=	Ki	nM	1.02	CHEMBL3023	Homo sapiens	Ki	nM	1.02
Dose-dependent effect	22919170	CHEMBL4736178	Inhibition of Sphk2 in human U-937 cells using FTY720 as substrate measured after 2 hrs by LC-MS analysis	B	CCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4750447		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
Dose-dependent effect	22919171	CHEMBL4736179	Inhibition of recombinant human Sphk2 expressed in yeast strain KYA1 assessed as increase in yeast growth measured after 24 hrs	B	CCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4750447		Inhibition	%		CHEMBL3023	Homo sapiens	INH		
	22919172	CHEMBL4736179	Inhibition of recombinant human Sphk2 expressed in yeast strain KYA1 assessed as increase in yeast growth measured after 24 hrs	B	CCCCCCCCCn1ccc2cc(-c3noc([C@@H]4CCCN4C(=N)N)n3)ccc21.Cl		CHEMBL4750447	=	EC50	nM	170.0	CHEMBL3023	Homo sapiens	EC50	nM	170.0
	22919174	CHEMBL4736181	Inhibition of recombinant human N-terminal His-tagged Sphk2 (2 to 593 residues) expressed in Escherichia coli using varying level of sphingosine as substrate by ADP quest assay	B	O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2		CHEMBL2158685	=	Ki	nM	9800.0	CHEMBL3023	Homo sapiens	Ki	nM	9800.0
	23124265	CHEMBL4806338	Inhibition of SPHK2 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	68.0	CHEMBL3023	Homo sapiens	INH	%	68.0
Not Active	23337775	CHEMBL4882146	SPHK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL3023	Homo sapiens	% Ctrl	%	97.0
Not Active	23352227	CHEMBL4882916	SPHK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.7387	CHEMBL3023	Homo sapiens	% Inhibition	%	-0.7387
